Australian Statistics on Medicines 2010
Table 2
COMMUNITY PRESCRIPTION DRUG USE, IN DDD/1000/DAY, FOR 2008 TO 2010
Table 2 lists most drugs on the Australian market by defined daily dose (DDD) per 1000 of the population per day from 2008 to 2010. To be listed in Table 2 the drugs need to have an assigned DDD. Items are arranged on the ATC code by generic name and the DDD/1000/day is given for both the subsidised ‘PBS/RPBS’ and the non-subsidised ‘survey’ components.
DDDs/1000 population/day for combination products are reported in terms of the DDD for each constituent where appropriate, ie, the ASM accounts for drugs in combination products as if they were administered as plain products. In editions prior to 2008, DDDs for combination products were not accounted for. For instance in atorvastatin and amlodipine combination product, the DDD component will be reported in 2 separate locations: the contribution to C10AA05 - Atorvastatin and C08CA01 – Amlodipine. DDDs entry for these drugs as a combination product is flagged as “combination” where the DDDs are part of a single product then the entry will be flagged as “plain”.
Note that not all combination products are included in table 2. Combination drugs will only be reported in terms of DDD of each constituent where:
- the constituent drugs were also available as plain drugs on the PBS;
- the combination was one of the usual forms of these drugs prescribed;
- the constituent drugs had independent actions ; and
- the WHO Defined Daily Dose was consistent across the various forms of the constituent drugs.
In addition, Anatomical Therapeutic Chemical (ATC) classification index with Defined Daily Doses (DDDs) 2011 is used in all statistics published in this edition (refer to WHO collaborating Centre for Drug Statistics Methodology, ATC classification index with DDDs 2011).
An index by the second level of the ATC classification follows:
A01 - STOMATOLOGICAL PREPARATIONS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| ALIMENTARY TRACT AND METABOLISM STOMATOLOGICAL PREPARATIONS STOMATOLOGICAL PREPARATIONS ANTIINFECTIVES FOR LOCAL ORAL TREATMENT |
|||||
| AMPHOTERICIN | |||||
| A01AB04 | PBS/RPBS | Plain | 0.081 | 0.076 | 0.072 |
| SURVEY | Plain | 0.031 | 0.027 | 0.024 | |
| CHLORHEXIDINE | |||||
| A01AB03 | PBS/RPBS | Plain | 0.004 | 0.003 | 0.003 |
| SURVEY | Plain | 0.002 | 0.002 | 0.002 | |
| MICONAZOLE | |||||
| A01AB09 | SURVEY | Plain | 0.002 | 0.002 | 0.002 |
| NYSTATIN | |||||
| A01AB11 | PBS/RPBS | Plain | 0.022 | 0.024 | 0.024 |
| SURVEY | Plain | 0.006 | 0.006 | 0.005 | |
A02 - DRUGS FOR ACID RELATED DISORDERS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| ALIMENTARY TRACT AND METABOLISM DRUGS FOR ACID RELATED DISORDERS DRUGS FOR PEPTIC ULCER AND GORD H2-RECEPTOR ANTAGONISTS |
|||||
| CIMETIDINE | |||||
| A02BA01 | PBS/RPBS | Plain | 0.087 | 0.075 | 0.044 |
| SURVEY | Plain | 0.030 | 0.029 | 0.025 | |
| FAMOTIDINE | |||||
| A02BA03 | PBS/RPBS | Plain | 0.428 | 0.365 | 0.323 |
| SURVEY | Plain | 0.089 | 0.074 | 0.058 | |
| NIZATIDINE | |||||
| A02BA04 | PBS/RPBS | Plain | 0.384 | 0.397 | 0.430 |
| SURVEY | Plain | 0.103 | 0.103 | 0.108 | |
| RANITIDINE HYDROCHLORIDE | |||||
| A02BA02 | PBS/RPBS | Plain | 3.428 | 3.065 | 2.871 |
| SURVEY | Plain | 0.632 | 0.574 | 0.552 | |
| PROSTAGLANDINS | |||||
| MISOPROSTOL | |||||
| A02BB01 | PBS/RPBS | Plain | 0.008 | 0.007 | 0.006 |
| PBS/RPBS | Combination | 0.002 | 0.001 | 0.001 | |
| PBS/RPBS | Total | 0.010 | 0.008 | 0.007 | |
| SURVEY | Plain | 0.001 | 0.001 | 0.002 | |
| SURVEY | Combination | 0.001 | 0.001 | 0.002 | |
| SURVEY | Total | 0.002 | 0.002 | 0.004 | |
| PROTON PUMP INHIBITORS | |||||
| ESOMEPRAZOLE | |||||
| A02BC05 | PBS/RPBS | Plain | 20.421 | 21.480 | 22.150 |
| SURVEY | Plain | 0.065 | 0.072 | 0.095 | |
| LANSOPRAZOLE | |||||
| A02BC03 | PBS/RPBS | Plain | 3.372 | 2.925 | 1.950 |
| SURVEY | Plain | 0.023 | 0.026 | 0.326 | |
| OMEPRAZOLE | |||||
| A02BC01 | PBS/RPBS | Plain | 14.920 | 12.323 | 11.491 |
| SURVEY | Plain | 1.202 | 2.603 | 2.285 | |
| SURVEY | Combination | 0.000 | 0.000 | 0.000 | |
| SURVEY | Total | 1.202 | 2.603 | 2.285 | |
| PANTOPRAZOLE | |||||
| A02BC02 | PBS/RPBS | Plain | 13.090 | 14.575 | 13.845 |
| SURVEY | Plain | 0.179 | 0.205 | 2.333 | |
| RABEPRAZOLE | |||||
| A02BC04 | PBS/RPBS | Plain | 8.699 | 9.253 | 9.842 |
| SURVEY | Plain | 0.030 | 0.028 | 0.038 | |
| OTHER DRUGS FOR PEPTIC ULCER AND GORD | |||||
| SUCRALFATE | |||||
| A02BX02 | PBS/RPBS | Plain | 0.043 | 0.044 | 0.047 |
A02 - DRUGS FOR ACID RELATED DISORDERS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| ALIMENTARY TRACT AND METABOLISM DRUGS FOR ACID RELATED DISORDERS DRUGS FOR PEPTIC ULCER AND GORD |
|||||
| SURVEY | Plain | 0.015 | 0.011 | 0.011 | |
A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| ALIMENTARY TRACT AND METABOLISM DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS DRUGS FOR FUNCTIONAL BOWEL DISORDERS SYNT ANTICHOLIN,ESTERS WITH TERTIARY AMINO GROUP |
|||||
| MEBEVERINE HYDROCHLORIDE | |||||
| A03AA04 | PBS/RPBS | Plain | 0.045 | 0.041 | 0.036 |
| SURVEY | Plain | 0.339 | 0.301 | 0.307 | |
| SYNT ANTICHOLINERGICS,ESTERS,QUATER AMMONIUM COMPOUND | |||||
| GLYCOPYRROLATE | |||||
| A03AB02 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| PROPANTHELINE | |||||
| A03AB05 | PBS/RPBS | Plain | 0.122 | 0.097 | 0.087 |
| SURVEY | Plain | 0.023 | 0.019 | 0.017 | |
| PAPAVERINE AND DERIVATIVES | |||||
| PAPAVERINE | |||||
| A03AD01 | SURVEY | Plain | 0.015 | 0.021 | 0.000 |
| BELLADONNA AND DERIVATIVES PLAIN | |||||
| BELLADONNA ALKALOIDS TERTIARY AMINES | |||||
| ATROPINE | |||||
| A03BA01 | PBS/RPBS | Plain | 0.006 | 0.006 | 0.006 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| HYOSCYAMINE HYDROBROMIDE with ATROPINE SULPHATE and HYOSCINE HYDROBROMIDE | |||||
| A03BA04 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| HYOSCYAMINE SULPHATE with ATROPINE SULPHATE with HYOSCINE HYDROBROMIDE | |||||
| A03BA04 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| BELLADONNA ALKALOIDS SEMISYNT QUATER AMMONIUM COMPOUND | |||||
| BUTYLSCOPOLAMINE | |||||
| A03BB01 | PBS/RPBS | Plain | 0.001 | 0.002 | 0.002 |
| SURVEY | Plain | 0.042 | 0.034 | 0.031 | |
| PROPULSIVES | |||||
| PROPULSIVES | |||||
| CISAPRIDE | |||||
| A03FA02 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| DOMPERIDONE | |||||
| A03FA03 | PBS/RPBS | Plain | 0.574 | 0.607 | 0.652 |
| SURVEY | Plain | 0.237 | 0.227 | 0.250 | |
| METOCLOPRAMIDE HYDROCHLORIDE | |||||
| A03FA01 | PBS/RPBS | Plain | 0.665 | 0.674 | 0.683 |
| SURVEY | Plain | 0.424 | 0.404 | 0.381 | |
| SURVEY | Combination | 0.000 | 0.000 | 0.000 | |
| SURVEY | Total | 0.424 | 0.404 | 0.381 | |
A04 - ANTIEMETICS AND ANTINAUSEANTS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| ALIMENTARY TRACT AND METABOLISM ANTIEMETICS AND ANTINAUSEANTS ANTIEMETICS AND ANTINAUSEANTS SEROTONIN (5HT3) ANTAGONISTS |
|||||
| DOLASETRON MESYLATE | |||||
| A04AA04 | PBS/RPBS | Plain | 0.005 | 0.005 | 0.004 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| GRANISETRON | |||||
| A04AA02 | PBS/RPBS | Plain | 0.022 | 0.026 | 0.027 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| ONDANSETRON | |||||
| A04AA01 | PBS/RPBS | Plain | 0.038 | 0.039 | 0.043 |
| SURVEY | Plain | 0.007 | 0.011 | 0.013 | |
| PALONOSETRON | |||||
| A04AA05 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| TROPISETRON | |||||
| A04AA03 | PBS/RPBS | Plain | 0.015 | 0.011 | 0.010 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| VARIOUS ANTIEMETICS | |||||
| APREPITANT | |||||
| A04AD12 | PBS/RPBS | Plain | 0.011 | 0.013 | 0.014 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| SCOPOLAMINE | |||||
| A04AD01 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
A05 - BILE AND LIVER THERAPY
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| ALIMENTARY TRACT AND METABOLISM BILE AND LIVER THERAPY BILE THERAPY BILE ACID PREPARATIONS |
|||||
| URSODEOXYCHOLIC ACID | |||||
| A05AA02 | PBS/RPBS | Plain | 0.167 | 0.187 | 0.198 |
| SURVEY | Plain | 0.002 | 0.005 | 0.006 | |
A06 - LAXATIVES
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| ALIMENTARY TRACT AND METABOLISM LAXATIVES LAXATIVES SOFTENERS EMOLLIENTS |
|||||
| DOCUSATE SODIUM | |||||
| A06AA02 | PBS/RPBS | Plain | 0.020 | 0.018 | 0.018 |
| SURVEY | Plain | 0.096 | 0.081 | 0.108 | |
| LIQUID PARAFFIN | |||||
| A06AA01 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| CONTACT LAXATIVES | |||||
| BISACODYL | |||||
| A06AB02 | PBS/RPBS | Plain | 0.537 | 0.472 | 0.441 |
| SURVEY | Plain | 0.028 | 0.028 | 0.024 | |
| BULK PRODUCERS | |||||
| PSYLLIUM HYDROPHILIC MUCILLOID | |||||
| A06AC01 | PBS/RPBS | Plain | 0.279 | 0.235 | 0.203 |
| SURVEY | Plain | 0.033 | 0.025 | 0.030 | |
| OSMOTICALLY ACTING LAXATIVES | |||||
| LACTULOSE | |||||
| A06AD11 | PBS/RPBS | Plain | 2.124 | 2.043 | 2.018 |
| SURVEY | Plain | 0.271 | 0.237 | 0.260 | |
| LACTULOSE with GALACTOSE with LACTOSE with EPILACTOSE | |||||
| A06AD11 | SURVEY | Plain | 0.001 | 0.000 | 0.001 |
| MACROGOL | |||||
| A06AD15 | PBS/RPBS | Plain | 1.690 | 2.700 | 3.628 |
| SURVEY | Plain | 0.189 | 0.190 | 0.195 | |
| SODIUM PHOSPHATE | |||||
| A06AD17 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| ENEMAS | |||||
| BISACODYL | |||||
| A06AG02 | PBS/RPBS | Plain | 0.003 | 0.002 | 0.002 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| PERIPHEROL OPIOID RECEPTOR ANTAGONISTS | |||||
| METHYLNALTREXONE BROMIDE | |||||
| A06AH01 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| OTHER LAXATIVES | |||||
| GLYCEROL | |||||
| A06AX01 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
A07 - ANTIDIARR. INTEST. ANTIINFL./ANTIINFECT. AGENTS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| ALIMENTARY TRACT AND METABOLISM ANTIDIARR. INTEST. ANTIINFL./ANTIINFECT. AGENTS INTESTINAL ANTIINFECTIVES ANTIBIOTICS |
|||||
| NEOMYCIN SULPHATE | |||||
| A07AA01 | PBS/RPBS | Plain | 0.000 | 0.001 | 0.000 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| NYSTATIN | |||||
| A07AA02 | PBS/RPBS | Plain | 0.080 | 0.074 | 0.071 |
| SURVEY | Plain | 0.076 | 0.069 | 0.068 | |
| VANCOMYCIN | |||||
| A07AA09 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| ANTIPROPULSIVES | |||||
| ANTIPROPULSIVES | |||||
| DIPHENOXYLATE HYDROCHLORIDE with ATROPINE SULPHATE | |||||
| A07DA01 | PBS/RPBS | Plain | 0.135 | 0.127 | 0.121 |
| SURVEY | Plain | 0.067 | 0.060 | 0.051 | |
| LOPERAMIDE HYDROCHLORIDE | |||||
| A07DA03 | PBS/RPBS | Plain | 0.293 | 0.294 | 0.301 |
| SURVEY | Plain | 0.062 | 0.060 | 0.053 | |
| INTESTINAL ANTIINFLAMMATORY AGENTS | |||||
| AMINOSALICYLIC ACID AND SIMILAR AGENTS | |||||
| BALSALAZIDE | |||||
| A07EC04 | PBS/RPBS | Plain | 0.053 | 0.060 | 0.064 |
| SURVEY | Plain | 0.001 | 0.000 | 0.000 | |
| MESALAZINE | |||||
| A07EC02 | PBS/RPBS | Plain | 0.965 | 1.071 | 1.180 |
| SURVEY | Plain | 0.009 | 0.005 | 0.008 | |
| OLSALAZINE SODIUM | |||||
| A07EC03 | PBS/RPBS | Plain | 0.155 | 0.138 | 0.128 |
| SURVEY | Plain | 0.001 | 0.001 | 0.000 | |
| SULPHASALAZINE | |||||
| A07EC01 | PBS/RPBS | Plain | 1.424 | 1.389 | 1.375 |
| SURVEY | Plain | 0.018 | 0.016 | 0.016 | |
A08 - ANTIOBESITY PREPARATIONS EXCL DIET PRODUCTS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| ALIMENTARY TRACT AND METABOLISM ANTIOBESITY PREPARATIONS EXCL DIET PRODUCTS ANTIOBESITY PREPARATIONS EXCL DIET PRODUCTS CENTRALLY ACTING ANTIOBESITY PRODUCTS |
|||||
| PHENTERMINE | |||||
| A08AA01 | SURVEY | Plain | 1.835 | 1.758 | 1.671 |
| SIBUTRAMINE | |||||
| A08AA10 | SURVEY | Plain | 0.823 | 0.791 | 0.397 |
| PERIPHERALLY ACTING ANTIOBESITY PRODUCTS | |||||
| ORLISTAT | |||||
| A08AB01 | PBS/RPBS | Plain | 0.003 | 0.002 | 0.001 |
| SURVEY | Plain | 0.018 | 0.016 | 0.008 | |
A10 - ANTIDIABETIC THERAPY
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| ALIMENTARY TRACT AND METABOLISM ANTIDIABETIC THERAPY INSULINS AND ANALOGUES INSULINS AND ANALOGUES FAST-ACTING |
|||||
| INSULIN (BEEF) | |||||
| A10AB02 | PBS/RPBS | Plain | 0.009 | 0.007 | 0.006 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| INSULIN (HUMAN) | |||||
| A10AB01 | PBS/RPBS | Plain | 0.818 | 0.682 | 0.598 |
| SURVEY | Plain | 0.006 | 0.006 | 0.005 | |
| INSULIN ASPART | |||||
| A10AB05 | PBS/RPBS | Plain | 3.026 | 3.366 | 3.694 |
| SURVEY | Plain | 0.030 | 0.030 | 0.029 | |
| INSULIN GLULISINE | |||||
| A10AB06 | PBS/RPBS | Plain | 0.121 | 0.228 | 0.272 |
| SURVEY | Plain | 0.000 | 0.001 | 0.001 | |
| INSULIN LISPRO | |||||
| A10AB04 | PBS/RPBS | Plain | 0.879 | 0.862 | 0.864 |
| SURVEY | Plain | 0.018 | 0.008 | 0.014 | |
| INSULINS AND ANALOGUES INTERMEDIATE-ACTING | |||||
| INSULIN (BEEF) | |||||
| A10AC02 | PBS/RPBS | Plain | 0.012 | 0.010 | 0.008 |
| SURVEY | Plain | 0.003 | 0.004 | 0.002 | |
| INSULIN (HUMAN) | |||||
| A10AC01 | PBS/RPBS | Plain | 1.749 | 1.394 | 1.180 |
| SURVEY | Plain | 0.029 | 0.028 | 0.025 | |
| INSULINS AND ANALOGUES INTERMEDIATE ACTING COMBINED WITH FAST-ACTING | |||||
| INSULIN (HUMAN) | |||||
| A10AD01 | PBS/RPBS | Plain | 2.643 | 2.275 | 2.046 |
| SURVEY | Plain | 0.051 | 0.042 | 0.025 | |
| INSULIN ASPART/PROTAMINE ASPART | |||||
| A10AD30 | PBS/RPBS | Plain | 2.633 | 2.846 | 3.183 |
| SURVEY | Plain | 0.018 | 0.026 | 0.015 | |
| INSULIN LISPRO | |||||
| A10AD04 | PBS/RPBS | Plain | 0.362 | 0.414 | 0.487 |
| SURVEY | Plain | 0.003 | 0.001 | 0.001 | |
| INSULINS AND ANALOGUES LONG-ACTING | |||||
| INSULIN DETEMIR | |||||
| A10AE05 | PBS/RPBS | Plain | 0.609 | 0.693 | 0.755 |
| SURVEY | Plain | 0.006 | 0.009 | 0.007 | |
| INSULIN GLARGINE | |||||
| A10AE04 | PBS/RPBS | Plain | 3.551 | 4.395 | 5.048 |
| SURVEY | Plain | 0.038 | 0.042 | 0.045 | |
| ORAL BLOOD GLUCOSE LOWERING DRUGS | |||||
| BIGUANIDES | |||||
A10 - ANTIDIABETIC THERAPY
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| ALIMENTARY TRACT AND METABOLISM ANTIDIABETIC THERAPY ORAL BLOOD GLUCOSE LOWERING DRUGS METFORMIN HYDROCHLORIDE |
|||||
| A10BA02 | PBS/RPBS | Plain | 12.102 | 12.624 | 13.197 |
| PBS/RPBS | Combination | 0.670 | 0.526 | 0.787 | |
| PBS/RPBS | Total | 12.772 | 13.150 | 13.984 | |
| SURVEY | Plain | 4.232 | 4.306 | 4.263 | |
| SURVEY | Combination | 0.107 | 0.098 | 0.097 | |
| SURVEY | Total | 4.339 | 4.404 | 4.360 | |
| SULFONAMIDES UREA DERIVATIVES | |||||
| GLIBENCLAMIDE | |||||
| A10BB01 | PBS/RPBS | Plain | 0.754 | 0.626 | 0.531 |
| PBS/RPBS | Combination | 0.429 | 0.434 | 0.430 | |
| PBS/RPBS | Total | 1.183 | 1.060 | 0.961 | |
| SURVEY | Plain | 0.149 | 0.121 | 0.100 | |
| SURVEY | Combination | 0.165 | 0.157 | 0.155 | |
| SURVEY | Total | 0.314 | 0.278 | 0.255 | |
| GLICLAZIDE | |||||
| A10BB09 | PBS/RPBS | Plain | 14.187 | 13.409 | 12.696 |
| SURVEY | Plain | 3.172 | 2.989 | 2.688 | |
| GLIMEPIRIDE | |||||
| A10BB12 | PBS/RPBS | Plain | 2.262 | 2.035 | 1.876 |
| SURVEY | Plain | 0.680 | 0.564 | 0.482 | |
| GLIPIZIDE | |||||
| A10BB07 | PBS/RPBS | Plain | 0.478 | 0.411 | 0.360 |
| SURVEY | Plain | 0.094 | 0.069 | 0.066 | |
| ALPHA GLUCOSIDASE INHIBITORS | |||||
| ACARBOSE | |||||
| A10BF01 | PBS/RPBS | Plain | 0.157 | 0.145 | 0.139 |
| SURVEY | Plain | 0.009 | 0.006 | 0.003 | |
| THIAZOLIDINEDIONES | |||||
| PIOGLITAZONE HYDROCHLORIDE | |||||
| A10BG03 | PBS/RPBS | Plain | 1.178 | 1.674 | 1.787 |
| SURVEY | Plain | 0.005 | 0.007 | 0.008 | |
| ROSIGLITAZONE | |||||
| A10BG02 | PBS/RPBS | Plain | 1.135 | 0.470 | 0.279 |
| PBS/RPBS | Combination | 0.479 | 0.270 | 0.217 | |
| PBS/RPBS | Total | 1.614 | 0.740 | 0.496 | |
| SURVEY | Plain | 0.005 | 0.003 | 0.002 | |
| SURVEY | Combination | 0.001 | 0.001 | 0.001 | |
| SURVEY | Total | 0.006 | 0.004 | 0.003 | |
| DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS | |||||
| SITAGLIPTIN | |||||
| A10BH01 | PBS/RPBS | Plain | 0.141 | 0.673 | 0.888 |
A10 - ANTIDIABETIC THERAPY
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| ALIMENTARY TRACT AND METABOLISM ANTIDIABETIC THERAPY ORAL BLOOD GLUCOSE LOWERING DRUGS |
|||||
| PBS/RPBS | Combination | 0.000 | 0.044 | 0.397 | |
| PBS/RPBS | Total | 0.141 | 0.717 | 1.285 | |
| SURVEY | Plain | 0.005 | 0.015 | 0.014 | |
| SURVEY | Combination | 0.000 | 0.000 | 0.002 | |
| SURVEY | Total | 0.005 | 0.015 | 0.016 | |
| VILDAGLIPTIN | |||||
| A10BH02 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.047 |
| SURVEY | Plain | 0.000 | 0.000 | 0.001 | |
| OTHER BLOOD GLUCOSE LOWERING DRUGS | |||||
| EXENATIDE | |||||
| A10BX04 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.036 |
| SURVEY | Plain | 0.002 | 0.007 | 0.007 | |
| REPAGLINIDE | |||||
| A10BX02 | SURVEY | Plain | 0.003 | 0.001 | 0.001 |
A11 - VITAMINS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| ALIMENTARY TRACT AND METABOLISM VITAMINS VITAMIN A AND D INCL COMBINATIONS OF THE TWO VITAMIN A PLAIN |
|||||
| VITAMIN A | |||||
| A11CA01 | SURVEY | Plain | 0.003 | 0.005 | 0.003 |
| VITAMIN D AND ANALOGUES | |||||
| CALCITRIOL | |||||
| A11CC04 | PBS/RPBS | Plain | 0.512 | 0.489 | 0.474 |
| SURVEY | Plain | 0.014 | 0.010 | 0.010 | |
| VITAMIN B1,PLAIN AND IN COMB. WITH VITAMIN B6 AND B12 | |||||
| THIAMINE (VITAMIN B1) PLAIN | |||||
| THIAMINE HYDROCHLORIDE | |||||
| A11DA01 | PBS/RPBS | Plain | 0.431 | 0.423 | 0.439 |
| SURVEY | Plain | 0.800 | 0.886 | 0.997 | |
| OTHER PLAIN VITAMIN PREPARATIONS | |||||
| OTHER PLAIN VITAMIN PREPARATIONS | |||||
| PYRIDOXINE HYDROCHLORIDE | |||||
| A11HA02 | SURVEY | Plain | 0.008 | 0.009 | 0.007 |
A12 - MINERAL SUPPLEMENTS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| ALIMENTARY TRACT AND METABOLISM MINERAL SUPPLEMENTS CALCIUM CALCIUM |
|||||
| CALCIUM (DIFFERENT SALTS IN COMBINATION) | |||||
| A12AA20 | SURVEY | Plain | 0.002 | 0.000 | 0.000 |
| CALCIUM CARBONATE | |||||
| A12AA04 | PBS/RPBS | Plain | 0.085 | 0.094 | 0.112 |
| PBS/RPBS | Combination | 1.205 | 1.519 | 1.500 | |
| PBS/RPBS | Total | 1.290 | 1.613 | 1.612 | |
| SURVEY | Plain | 0.256 | 0.197 | 0.188 | |
| SURVEY | Combination | 0.040 | 0.043 | 0.029 | |
| SURVEY | Total | 0.296 | 0.240 | 0.217 | |
| CALCIUM, COMBINATIONS WITH OTHER DRUGS | |||||
| CALCIUM CARBONATE with CHOLECALCIFEROL | |||||
| A12AX | SURVEY | Plain | 0.019 | 0.017 | 0.017 |
| POTASSIUM | |||||
| POTASSIUM | |||||
| POTASSIUM CHLORIDE | |||||
| A12BA01 | PBS/RPBS | Plain | 1.528 | 1.436 | 1.372 |
| SURVEY | Plain | 0.166 | 0.153 | 0.144 | |
| OTHER MINERAL SUPPLEMENTS | |||||
| ZINC | |||||
| ZINC SULPHATE | |||||
| A12CB01 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| SELENIUM | |||||
| SELENIUM | |||||
| A12CE01 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
A14 - ANABOLIC AGENTS FOR SYSTEMIC USE
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| ALIMENTARY TRACT AND METABOLISM ANABOLIC AGENTS FOR SYSTEMIC USE ANABOLIC STEROIDS ESTREN DERIVATIVES |
|||||
| NANDROLONE DECANOATE | |||||
| A14AB01 | PBS/RPBS | Plain | 0.033 | 0.027 | 0.022 |
| SURVEY | Plain | 0.020 | 0.018 | 0.013 | |
B01 - ANTITHROMBOTIC AGENTS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| BLOOD AND BLOOD FORMING ORGANS ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS VITAMIN K ANTAGONISTS |
|||||
| PHENINDIONE | |||||
| B01AA02 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| WARFARIN | |||||
| B01AA03 | PBS/RPBS | Plain | 5.061 | 5.085 | 5.273 |
| SURVEY | Plain | 1.195 | 1.156 | 1.168 | |
| HEPARIN GROUP | |||||
| DALTEPARIN | |||||
| B01AB04 | PBS/RPBS | Plain | 0.062 | 0.051 | 0.047 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| ENOXAPARIN | |||||
| B01AB05 | PBS/RPBS | Plain | 1.420 | 1.668 | 1.915 |
| SURVEY | Plain | 0.025 | 0.016 | 0.022 | |
| HEPARIN CALCIUM | |||||
| B01AB01 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| HEPARIN SODIUM | |||||
| B01AB01 | PBS/RPBS | Plain | 0.033 | 0.034 | 0.041 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| HEPARINISED SALINE | |||||
| B01AB01 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| PLATELET AGGREGATION INHIBITORS EXCL. HEPARIN | |||||
| ABCIXIMAB | |||||
| B01AC13 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| ASPIRIN | |||||
| B01AC06 | PBS/RPBS | Plain | 18.000 | 17.011 | 15.947 |
| PBS/RPBS | Combination | 0.958 | 0.961 | 1.864 | |
| PBS/RPBS | Total | 18.958 | 17.972 | 17.811 | |
| SURVEY | Plain | 1.421 | 1.376 | 1.226 | |
| SURVEY | Combination | 0.003 | 0.002 | 0.003 | |
| SURVEY | Total | 1.424 | 1.378 | 1.229 | |
| CLOPIDOGREL | |||||
| B01AC04 | PBS/RPBS | Plain | 9.894 | 10.417 | 10.007 |
| PBS/RPBS | Combination | 0.000 | 0.008 | 0.927 | |
| PBS/RPBS | Total | 9.894 | 10.425 | 10.934 | |
| SURVEY | Plain | 0.055 | 0.052 | 0.038 | |
| SURVEY | Combination | 0.000 | 0.000 | 0.002 | |
| SURVEY | Total | 0.055 | 0.052 | 0.040 | |
| DIPYRIDAMOLE | |||||
| B01AC07 | PBS/RPBS | Plain | 0.202 | 0.177 | 0.155 |
| PBS/RPBS | Combination | 1.915 | 1.905 | 1.875 | |
| PBS/RPBS | Total | 2.117 | 2.082 | 2.030 | |
| SURVEY | Plain | 0.004 | 0.004 | 0.003 | |
B01 - ANTITHROMBOTIC AGENTS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| BLOOD AND BLOOD FORMING ORGANS ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS |
|||||
| SURVEY | Combination | 0.005 | 0.004 | 0.003 | |
| SURVEY | Total | 0.009 | 0.008 | 0.006 | |
| EPTIFIBATIDE | |||||
| B01AC16 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| ILOPROST | |||||
| B01AC11 | PBS/RPBS | Plain | 0.001 | 0.001 | 0.001 |
| PRASUGREL | |||||
| B01AC22 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.035 |
| TICLOPIDINE HYDROCHLORIDE | |||||
| B01AC05 | PBS/RPBS | Plain | 0.009 | 0.006 | 0.004 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| TIROFIBAN | |||||
| B01AC17 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| ENZYMES | |||||
| DROTRECOGIN ALFA | |||||
| B01AD10 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| RETEPLASE | |||||
| B01AD07 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| TENECTEPLASE | |||||
| B01AD11 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| DIRECT THROMBIN INHIBITORS | |||||
| BIVALIRUDIN | |||||
| B01AE06 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| DABIGATRAN | |||||
| B01AE07 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| OTHER ANTITHROMBOTIC AGENTS | |||||
| FONDAPARINUX SODIUM | |||||
| B01AX05 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| RIVAROXABAN | |||||
| B01AX06 | PBS/RPBS | Plain | 0.000 | 0.009 | 0.080 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
B02 - ANTIHAEMORRHAGICS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| BLOOD AND BLOOD FORMING ORGANS ANTIHAEMORRHAGICS ANTIFIBRINOLYTICS AMINO ACIDS |
|||||
| TRANEXAMIC ACID | |||||
| B02AA02 | PBS/RPBS | Plain | 0.111 | 0.120 | 0.126 |
| SURVEY | Plain | 0.002 | 0.003 | 0.003 | |
| VITAMIN K AND OTHER HAEMOSTATICS | |||||
| VITAMIN K | |||||
| PHYTOMENADIONE | |||||
| B02BA01 | SURVEY | Plain | 0.007 | 0.004 | 0.001 |
B03 - ANTIANAEMIC PREPARATIONS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| BLOOD AND BLOOD FORMING ORGANS ANTIANAEMIC PREPARATIONS IRON PREPARATIONS IRON BIVALENT, ORAL PREPARATIONS |
|||||
| FERROUS GLUCONATE | |||||
| B03AA03 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| FERROUS SULPHATE | |||||
| B03AA07 | PBS/RPBS | Plain | 0.037 | 0.036 | 0.037 |
| SURVEY | Plain | 0.428 | 0.429 | 0.389 | |
| IRON TRIVALENT, PARENTERAL PREPARATIONS | |||||
| IRON POLYMALTOSE COMPLEX | |||||
| B03AC03 | PBS/RPBS | Plain | 0.033 | 0.034 | 0.037 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| SACCHARATED IRON OXIDE | |||||
| B03AC02 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| VITAMIN B12 AND FOLIC ACID | |||||
| VITAMIN B12 (CYANOCOBALAMIN AND DERIVATIVES) | |||||
| CYANOCOBALAMIN | |||||
| B03BA01 | SURVEY | Plain | 0.001 | 0.000 | 0.000 |
| HYDROXOCOBALAMIN | |||||
| B03BA03 | PBS/RPBS | Plain | 5.541 | 5.403 | 5.495 |
| SURVEY | Plain | 0.767 | 0.738 | 0.739 | |
| FOLIC ACID AND DERIVATIVES | |||||
| FOLIC ACID | |||||
| B03BB01 | PBS/RPBS | Plain | 1.569 | 1.467 | 1.329 |
| SURVEY | Plain | 0.135 | 0.156 | 0.133 | |
| OTHER ANTIANAEMIC PREPARATIONS | |||||
| OTHER ANTIANAEMIC PREPARATIONS | |||||
| DARBEPOETIN ALPHA | |||||
| B03XA02 | PBS/RPBS | Plain | 0.181 | 0.185 | 0.181 |
| SURVEY | Plain | 0.001 | 0.001 | 0.001 | |
| EPOETIN ALPHA | |||||
| B03XA01 | PBS/RPBS | Plain | 0.041 | 0.031 | 0.028 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| EPOETIN BETA | |||||
| B03XA01 | PBS/RPBS | Plain | 0.017 | 0.030 | 0.033 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| ERYTHROPOIETIN | |||||
| B03XA01 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA | |||||
| B03XA03 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.004 |
C01 - CARDIAC THERAPY
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| CARDIOVASCULAR SYSTEM CARDIAC THERAPY CARDIAC GLYCOSIDES DIGITALIS GLYCOSIDES |
|||||
| DIGOXIN | |||||
| C01AA05 | PBS/RPBS | Plain | 3.493 | 3.210 | 3.023 |
| SURVEY | Plain | 0.447 | 0.405 | 0.383 | |
| ANTIARRHYTHMICS CLASS I AND III | |||||
| ANTIARRHYTHMICS CLASS IA | |||||
| DISOPYRAMIDE | |||||
| C01BA03 | PBS/RPBS | Plain | 0.032 | 0.030 | 0.026 |
| SURVEY | Plain | 0.004 | 0.003 | 0.002 | |
| ANTIARRHYTHMICS CLASS IB | |||||
| LIGNOCAINE HYDROCHLORIDE | |||||
| C01BB01 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| MEXILETINE HYDROCHLORIDE | |||||
| C01BB02 | PBS/RPBS | Plain | 0.015 | 0.015 | 0.011 |
| SURVEY | Plain | 0.000 | 0.001 | 0.000 | |
| ANTIARRHYTHMICS CLASS IC | |||||
| FLECAINIDE ACETATE | |||||
| C01BC04 | PBS/RPBS | Plain | 0.535 | 0.567 | 0.612 |
| SURVEY | Plain | 0.002 | 0.002 | 0.003 | |
| ANTIARRHYTHMICS CLASS III | |||||
| AMIODARONE HYDROCHLORIDE | |||||
| C01BD01 | PBS/RPBS | Plain | 1.183 | 1.115 | 1.074 |
| SURVEY | Plain | 0.131 | 0.123 | 0.118 | |
| CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES | |||||
| ADRENERGIC AGENTS | |||||
| ADRENALINE | |||||
| C01CA24 | PBS/RPBS | Plain | 0.041 | 0.040 | 0.042 |
| SURVEY | Plain | 0.003 | 0.003 | 0.003 | |
| EPHEDRINE | |||||
| C01CA26 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| VASODILATORS USED IN CARDIAC DISEASES | |||||
| ORGANIC NITRATES | |||||
| GLYCERYL TRINITRATE | |||||
| C01DA02 | PBS/RPBS | Plain | 4.448 | 4.081 | 3.800 |
| SURVEY | Plain | 0.211 | 0.197 | 0.179 | |
| ISOSORBIDE DINITRATE | |||||
| C01DA08 | PBS/RPBS | Plain | 0.114 | 0.100 | 0.089 |
| SURVEY | Plain | 0.006 | 0.005 | 0.005 | |
| ISOSORBIDE MONONITRATE | |||||
| C01DA14 | PBS/RPBS | Plain | 7.446 | 6.921 | 6.564 |
| SURVEY | Plain | 0.415 | 0.405 | 0.337 | |
C01 - CARDIAC THERAPY
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| CARDIOVASCULAR SYSTEM CARDIAC THERAPY VASODILATORS USED IN CARDIAC DISEASES OTHER VASODILATORS USED IN CARDIAC DISEASES |
|||||
| NICORANDIL | |||||
| C01DX16 | PBS/RPBS | Plain | 0.010 | 0.010 | 0.010 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| OTHER CARDIAC PREPARATIONS | |||||
| OTHER CARDIAC PREPARATIONS | |||||
| ADENOSINE | |||||
| C01EB10 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| IVABRADINE | |||||
| C01EB17 | SURVEY | Plain | 0.000 | 0.008 | 0.052 |
C02 - ANTIHYPERTENSIVES
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| CARDIOVASCULAR SYSTEM ANTIHYPERTENSIVES ANTIADRENERGIC AGENTS CENTRALLY ACTING METHYLDOPA |
|||||
| METHYLDOPA | |||||
| C02AB01 | PBS/RPBS | Plain | 0.452 | 0.448 | 0.437 |
| SURVEY | Plain | 0.105 | 0.097 | 0.091 | |
| IMIDAZOLINE RECEPTOR AGONISTS | |||||
| CLONIDINE | |||||
| C02AC01 | PBS/RPBS | Plain | 0.358 | 0.360 | 0.366 |
| SURVEY | Plain | 0.071 | 0.062 | 0.063 | |
| MOXONIDINE | |||||
| C02AC05 | PBS/RPBS | Plain | 0.200 | 0.513 | 0.980 |
| SURVEY | Plain | 0.050 | 0.139 | 0.271 | |
| ANTIADRENERGIC AGENTS PERIPHERALLY ACTING | |||||
| ALPHA - ADRENOCEPTOR BLOCKING AGENTS | |||||
| PRAZOSIN HYDROCHLORIDE | |||||
| C02CA01 | PBS/RPBS | Plain | 3.003 | 2.944 | 2.820 |
| SURVEY | Plain | 0.523 | 0.503 | 0.465 | |
| ARTERIOLAR SMOOTH MUSCLE AGENTS ACTING ON | |||||
| HYDRAZINOPHTHALAZINE DERIVATIVES | |||||
| HYDRALAZINE HYDROCHLORIDE | |||||
| C02DB02 | PBS/RPBS | Plain | 0.413 | 0.431 | 0.460 |
| SURVEY | Plain | 0.089 | 0.087 | 0.083 | |
| PYRIMIDINE DERIVATIVES | |||||
| MINOXIDIL | |||||
| C02DC01 | PBS/RPBS | Plain | 0.029 | 0.030 | 0.030 |
| SURVEY | Plain | 0.006 | 0.007 | 0.006 | |
| OTHER ANTIHYPERTENSIVES | |||||
| OTHER ANTHIYPERTENSIVES | |||||
| AMBRISENTAN | |||||
| C02KX02 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.002 |
| BOSENTAN | |||||
| C02KX01 | PBS/RPBS | Plain | 0.025 | 0.030 | 0.028 |
| SURVEY | Plain | 0.000 | 0.000 | 0.001 | |
| SITAXENTAN | |||||
| C02KX03 | PBS/RPBS | Plain | 0.001 | 0.005 | 0.005 |
C03 - DIURETICS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| CARDIOVASCULAR SYSTEM DIURETICS LOW-CEILING DIURETICS THIAZIDES THIAZIDES PLAIN |
|||||
| HYDROCHLOROTHIAZIDE | |||||
| C03AA03 | PBS/RPBS | Plain | 0.915 | 0.897 | 0.898 |
| PBS/RPBS | Combination | 9.987 | 9.940 | 10.416 | |
| PBS/RPBS | Total | 10.902 | 10.837 | 11.314 | |
| SURVEY | Plain | 0.286 | 0.274 | 0.238 | |
| SURVEY | Combination | 3.005 | 3.551 | 3.272 | |
| SURVEY | Total | 3.291 | 3.825 | 3.510 | |
| LOW-CEILING DIURETICS EXCL. THIAZIDES | |||||
| SULFONAMIDES PLAIN | |||||
| CHLORTHALIDONE | |||||
| C03BA04 | PBS/RPBS | Plain | 0.339 | 0.306 | 0.286 |
| SURVEY | Plain | 0.107 | 0.095 | 0.082 | |
| INDAPAMIDE | |||||
| C03BA11 | PBS/RPBS | Plain | 4.181 | 3.762 | 3.401 |
| PBS/RPBS | Combination | 2.544 | 2.501 | 2.420 | |
| PBS/RPBS | Total | 6.725 | 6.263 | 5.821 | |
| SURVEY | Plain | 1.215 | 1.027 | 0.914 | |
| SURVEY | Combination | 1.155 | 1.055 | 0.955 | |
| SURVEY | Total | 2.370 | 2.082 | 1.869 | |
| HIGH-CEILING DIURETICS | |||||
| SULFONAMIDES PLAIN | |||||
| BUMETANIDE | |||||
| C03CA02 | SURVEY | Plain | 0.082 | 0.071 | 0.075 |
| FRUSEMIDE | |||||
| C03CA01 | PBS/RPBS | Plain | 17.731 | 17.165 | 17.029 |
| SURVEY | Plain | 1.329 | 1.289 | 1.213 | |
| ARYLOXYACETIC ACID DERIVATIVES | |||||
| ETHACRYNIC ACID | |||||
| C03CC01 | PBS/RPBS | Plain | 0.026 | 0.026 | 0.027 |
| SURVEY | Plain | 0.001 | 0.000 | 0.000 | |
| POTASSIUM-SPARING AGENTS | |||||
| ALDOSTERONE ANTAGONISTS | |||||
| EPLERENONE | |||||
| C03DA04 | PBS/RPBS | Plain | 0.016 | 0.021 | 0.026 |
| SURVEY | Plain | 0.001 | 0.001 | 0.002 | |
| SPIRONOLACTONE | |||||
| C03DA01 | PBS/RPBS | Plain | 1.998 | 1.692 | 1.738 |
| SURVEY | Plain | 0.384 | 0.648 | 0.568 | |
| OTHER POTASSIUM-SPARING AGENTS | |||||
| AMILORIDE HYDROCHLORIDE | |||||
| C03DB01 | PBS/RPBS | Plain | 0.123 | 0.112 | 0.104 |
C03 - DIURETICS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| CARDIOVASCULAR SYSTEM DIURETICS POTASSIUM-SPARING AGENTS |
|||||
| SURVEY | Plain | 0.043 | 0.037 | 0.037 | |
C04 - PERIPHERAL VASODILATORS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| CARDIOVASCULAR SYSTEM PERIPHERAL VASODILATORS PERIPHERAL VASODILATORS IMIDAZOLINE DERIVATIVES |
|||||
| PHENTOLAMINE MESYLATE | |||||
| C04AB01 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| PURINE DERIVATIVES | |||||
| OXPENTIFYLLINE | |||||
| C04AD03 | SURVEY | Plain | 0.003 | 0.004 | 0.002 |
| OTHER PERIPHERAL VASODILATORS | |||||
| CILOSTAZOL | |||||
| C04AX33 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| PHENOXYBENZAMINE HYDROCHLORIDE | |||||
| C04AX02 | PBS/RPBS | Plain | 0.006 | 0.009 | 0.008 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
C07 - BETA BLOCKING AGENTS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| CARDIOVASCULAR SYSTEM BETA BLOCKING AGENTS BETA BLOCKING AGENTS PLAIN BETA BLOCKING AGENTS PLAIN NON-SELECTIVE |
|||||
| OXPRENOLOL HYDROCHLORIDE | |||||
| C07AA02 | PBS/RPBS | Plain | 0.024 | 0.021 | 0.019 |
| SURVEY | Plain | 0.014 | 0.013 | 0.015 | |
| PINDOLOL | |||||
| C07AA03 | PBS/RPBS | Plain | 0.220 | 0.192 | 0.170 |
| SURVEY | Plain | 0.041 | 0.034 | 0.029 | |
| PROPRANOLOL HYDROCHLORIDE | |||||
| C07AA05 | PBS/RPBS | Plain | 0.880 | 0.846 | 0.836 |
| SURVEY | Plain | 0.468 | 0.418 | 0.410 | |
| SOTALOL HYDROCHLORIDE | |||||
| C07AA07 | PBS/RPBS | Plain | 1.826 | 1.747 | 1.738 |
| SURVEY | Plain | 0.442 | 0.445 | 0.425 | |
| BETA BLOCKING AGENTS PLAIN SELECTIVE | |||||
| ATENOLOL | |||||
| C07AB03 | PBS/RPBS | Plain | 9.273 | 8.874 | 8.555 |
| SURVEY | Plain | 2.896 | 2.622 | 2.387 | |
| BISOPROLOL | |||||
| C07AB07 | PBS/RPBS | Plain | 0.663 | 0.857 | 1.070 |
| SURVEY | Plain | 0.006 | 0.009 | 0.007 | |
| METOPROLOL SUCCINATE | |||||
| C07AB02 | PBS/RPBS | Plain | 0.231 | 0.259 | 0.281 |
| SURVEY | Plain | 0.002 | 0.001 | 0.000 | |
| METOPROLOL TARTRATE | |||||
| C07AB02 | PBS/RPBS | Plain | 6.139 | 6.147 | 6.274 |
| SURVEY | Plain | 1.435 | 1.390 | 1.334 | |
| NEBIVOLOL | |||||
| C07AB12 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.022 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| ALPHA- AND BETA- ADRENOCEPTOR BLOCKING AGENTS | |||||
| CARVEDILOL | |||||
| C07AG02 | PBS/RPBS | Plain | 2.055 | 1.990 | 1.918 |
| SURVEY | Plain | 0.008 | 0.010 | 0.008 | |
| LABETALOL HYDROCHLORIDE | |||||
| C07AG01 | PBS/RPBS | Plain | 0.090 | 0.089 | 0.087 |
| SURVEY | Plain | 0.051 | 0.050 | 0.048 | |
C08 - CALCIUM CHANNEL BLOCKERS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| CARDIOVASCULAR SYSTEM CALCIUM CHANNEL BLOCKERS SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS DIHYDROPYRIDINE DERIVATIVES |
|||||
| AMLODIPINE | |||||
| C08CA01 | PBS/RPBS | Plain | 12.507 | 12.572 | 12.469 |
| PBS/RPBS | Combination | 3.142 | 4.340 | 6.300 | |
| PBS/RPBS | Total | 15.649 | 16.912 | 18.769 | |
| SURVEY | Plain | 4.260 | 4.082 | 3.811 | |
| SURVEY | Combination | 0.007 | 0.008 | 0.039 | |
| SURVEY | Total | 4.267 | 4.090 | 3.850 | |
| FELODIPINE | |||||
| C08CA02 | PBS/RPBS | Plain | 6.289 | 5.856 | 5.410 |
| PBS/RPBS | Combination | 0.148 | 0.193 | 0.223 | |
| PBS/RPBS | Total | 6.437 | 6.049 | 5.633 | |
| SURVEY | Plain | 1.449 | 1.276 | 1.117 | |
| SURVEY | Combination | 0.043 | 0.102 | 0.103 | |
| SURVEY | Total | 1.492 | 1.378 | 1.220 | |
| LERCANIPIDINE | |||||
| C08CA13 | PBS/RPBS | Plain | 8.260 | 8.964 | 9.058 |
| PBS/RPBS | Combination | 0.040 | 0.242 | 0.352 | |
| PBS/RPBS | Total | 8.300 | 9.206 | 9.410 | |
| SURVEY | Plain | 2.377 | 2.432 | 2.385 | |
| SURVEY | Combination | 0.008 | 0.036 | 0.089 | |
| SURVEY | Total | 2.385 | 2.468 | 2.474 | |
| NIFEDIPINE | |||||
| C08CA05 | PBS/RPBS | Plain | 3.997 | 3.710 | 3.442 |
| SURVEY | Plain | 1.042 | 0.958 | 0.857 | |
| SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS | |||||
| PHENYLALKYLAMINE DERIVATIVES | |||||
| VERAPAMIL HYDROCHLORIDE | |||||
| C08DA01 | PBS/RPBS | Plain | 3.489 | 3.265 | 3.091 |
| PBS/RPBS | Combination | 0.129 | 0.195 | 0.145 | |
| PBS/RPBS | Total | 3.618 | 3.460 | 3.236 | |
| SURVEY | Plain | 0.860 | 0.782 | 0.718 | |
| SURVEY | Combination | 0.001 | 0.006 | 0.098 | |
| SURVEY | Total | 0.861 | 0.788 | 0.816 | |
| BENZOTHIAZEPINE DERIVATIVES | |||||
| DILTIAZEM HYDROCHLORIDE | |||||
| C08DB01 | PBS/RPBS | Plain | 4.503 | 4.280 | 4.118 |
| SURVEY | Plain | 0.906 | 0.826 | 0.786 | |
| NON-SELECTIVE CALCIUM CHANNEL BLOCKERS | |||||
| OTHER NON-SELECTIVE CALCIUM CHANNEL BLOCKERS | |||||
| PERHEXILINE MALEATE | |||||
| C08EX02 | PBS/RPBS | Plain | 0.208 | 0.197 | 0.187 |
C08 - CALCIUM CHANNEL BLOCKERS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| CARDIOVASCULAR SYSTEM CALCIUM CHANNEL BLOCKERS NON-SELECTIVE CALCIUM CHANNEL BLOCKERS |
|||||
| SURVEY | Plain | 0.003 | 0.002 | 0.001 | |
C09 - AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| CARDIOVASCULAR SYSTEM AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS, PLAIN CONVERTING ENZYME BLOCKERS |
|||||
| CAPTOPRIL | |||||
| C09AA01 | PBS/RPBS | Plain | 0.732 | 0.581 | 0.454 |
| SURVEY | Plain | 0.024 | 0.023 | 0.031 | |
| ENALAPRIL MALEATE | |||||
| C09AA02 | PBS/RPBS | Plain | 3.860 | 3.352 | 2.929 |
| PBS/RPBS | Combination | 0.993 | 1.276 | 1.385 | |
| PBS/RPBS | Total | 4.853 | 4.628 | 4.314 | |
| SURVEY | Plain | 0.960 | 0.771 | 0.635 | |
| SURVEY | Combination | 0.346 | 0.337 | 0.401 | |
| SURVEY | Total | 1.306 | 1.108 | 1.036 | |
| FOSINOPRIL | |||||
| C09AA09 | PBS/RPBS | Plain | 1.485 | 1.337 | 1.212 |
| PBS/RPBS | Combination | 1.815 | 1.673 | 1.532 | |
| PBS/RPBS | Total | 3.300 | 3.010 | 2.744 | |
| SURVEY | Plain | 0.417 | 0.344 | 0.289 | |
| SURVEY | Combination | 0.718 | 0.604 | 0.511 | |
| SURVEY | Total | 1.135 | 0.948 | 0.800 | |
| LISINOPRIL | |||||
| C09AA03 | PBS/RPBS | Plain | 3.594 | 3.221 | 2.913 |
| SURVEY | Plain | 1.137 | 0.948 | 0.809 | |
| PERINDOPRIL | |||||
| C09AA04 | PBS/RPBS | Plain | 21.711 | 22.410 | 22.665 |
| PBS/RPBS | Combination | 6.181 | 6.016 | 6.667 | |
| PBS/RPBS | Total | 27.892 | 28.426 | 29.332 | |
| SURVEY | Plain | 9.120 | 9.070 | 8.757 | |
| SURVEY | Combination | 2.804 | 2.525 | 2.302 | |
| SURVEY | Total | 11.924 | 11.595 | 11.059 | |
| QUINAPRIL | |||||
| C09AA06 | PBS/RPBS | Plain | 1.501 | 1.324 | 1.122 |
| PBS/RPBS | Combination | 0.398 | 0.376 | 0.358 | |
| PBS/RPBS | Total | 1.899 | 1.700 | 1.480 | |
| SURVEY | Plain | 0.419 | 0.344 | 0.317 | |
| SURVEY | Combination | 0.178 | 0.160 | 0.145 | |
| SURVEY | Total | 0.597 | 0.504 | 0.462 | |
| RAMIPRIL | |||||
| C09AA05 | PBS/RPBS | Plain | 28.395 | 27.455 | 26.455 |
| PBS/RPBS | Combination | 0.297 | 0.386 | 0.447 | |
| PBS/RPBS | Total | 28.692 | 27.841 | 26.902 | |
| SURVEY | Plain | 11.454 | 10.320 | 9.361 | |
| SURVEY | Combination | 0.086 | 0.205 | 0.206 | |
| SURVEY | Total | 11.540 | 10.525 | 9.567 | |
C09 - AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| CARDIOVASCULAR SYSTEM AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS, PLAIN TRANDOLAPRIL |
|||||
| C09AA10 | PBS/RPBS | Plain | 1.653 | 1.504 | 1.364 |
| PBS/RPBS | Combination | 0.129 | 0.198 | 0.151 | |
| PBS/RPBS | Total | 1.782 | 1.702 | 1.515 | |
| SURVEY | Plain | 0.560 | 0.511 | 0.452 | |
| SURVEY | Combination | 0.001 | 0.008 | 0.102 | |
| SURVEY | Total | 0.561 | 0.519 | 0.554 | |
| ANGIOTENSIN II ANTAGONISTS | |||||
| ANGIOTENSIN II ANTAGONISTS PLAIN | |||||
| CANDESARTAN | |||||
| C09CA06 | PBS/RPBS | Plain | 13.627 | 15.476 | 16.621 |
| PBS/RPBS | Combination | 6.591 | 5.804 | 7.202 | |
| PBS/RPBS | Total | 20.218 | 21.280 | 23.823 | |
| SURVEY | Plain | 3.516 | 3.420 | 3.308 | |
| SURVEY | Combination | 1.660 | 2.589 | 2.322 | |
| SURVEY | Total | 5.176 | 6.009 | 5.630 | |
| EPROSARTAN | |||||
| C09CA02 | PBS/RPBS | Plain | 0.395 | 0.342 | 0.299 |
| PBS/RPBS | Combination | 0.305 | 0.291 | 0.228 | |
| PBS/RPBS | Total | 0.700 | 0.633 | 0.527 | |
| SURVEY | Plain | 0.128 | 0.096 | 0.082 | |
| SURVEY | Combination | 0.074 | 0.051 | 0.084 | |
| SURVEY | Total | 0.202 | 0.147 | 0.166 | |
| IRBESARTAN | |||||
| C09CA04 | PBS/RPBS | Plain | 16.847 | 16.568 | 16.203 |
| PBS/RPBS | Combination | 19.357 | 17.532 | 17.404 | |
| PBS/RPBS | Total | 36.204 | 34.100 | 33.607 | |
| SURVEY | Plain | 6.662 | 6.133 | 5.592 | |
| SURVEY | Combination | 4.865 | 6.141 | 5.357 | |
| SURVEY | Total | 11.527 | 12.274 | 10.949 | |
| LOSARTAN | |||||
| C09CA01 | SURVEY | Plain | 0.015 | 0.010 | 0.007 |
| OLMESARTAN MEDOXOMIL | |||||
| C09CA08 | PBS/RPBS | Plain | 0.545 | 1.058 | 1.489 |
| PBS/RPBS | Combination | 0.633 | 1.197 | 1.735 | |
| PBS/RPBS | Total | 1.178 | 2.255 | 3.224 | |
| SURVEY | Plain | 0.328 | 0.661 | 0.945 | |
| SURVEY | Combination | 0.076 | 0.305 | 0.450 | |
| SURVEY | Total | 0.404 | 0.966 | 1.395 | |
| TELMISARTAN | |||||
| C09CA07 | PBS/RPBS | Plain | 7.383 | 8.078 | 8.684 |
| PBS/RPBS | Combination | 4.654 | 5.212 | 5.368 | |
C09 - AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| CARDIOVASCULAR SYSTEM AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM ANGIOTENSIN II ANTAGONISTS |
|||||
| PBS/RPBS | Total | 12.037 | 13.290 | 14.052 | |
| SURVEY | Plain | 3.520 | 3.721 | 3.932 | |
| SURVEY | Combination | 2.473 | 2.562 | 2.502 | |
| SURVEY | Total | 5.993 | 6.283 | 6.434 | |
| VALSARTAN | |||||
| C09CA03 | PBS/RPBS | Plain | 0.000 | 0.064 | 0.282 |
| PBS/RPBS | Combination | 0.000 | 0.001 | 0.074 | |
| PBS/RPBS | Total | 0.000 | 0.065 | 0.356 | |
| SURVEY | Plain | 0.000 | 0.033 | 0.149 | |
| SURVEY | Combination | 0.000 | 0.000 | 0.023 | |
| SURVEY | Total | 0.000 | 0.033 | 0.172 | |
C10 - LIPID MODIFYING AGENTS PLAIN
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| CARDIOVASCULAR SYSTEM LIPID MODIFYING AGENTS PLAIN LIPID MODIFYING AGENTS PLAIN HMG REDUCTASE INHIBITORS |
|||||
| ATORVASTATIN | |||||
| C10AA05 | PBS/RPBS | Plain | 67.749 | 69.043 | 69.235 |
| PBS/RPBS | Combination | 7.190 | 10.139 | 13.520 | |
| PBS/RPBS | Total | 74.939 | 79.182 | 82.755 | |
| SURVEY | Plain | 0.180 | 0.169 | 0.102 | |
| SURVEY | Combination | 0.013 | 0.016 | 0.015 | |
| SURVEY | Total | 0.193 | 0.185 | 0.117 | |
| FLUVASTATIN | |||||
| C10AA04 | PBS/RPBS | Plain | 0.213 | 0.219 | 0.208 |
| SURVEY | Plain | 0.026 | 0.024 | 0.017 | |
| PRAVASTATIN | |||||
| C10AA03 | PBS/RPBS | Plain | 7.230 | 6.206 | 5.496 |
| SURVEY | Plain | 0.096 | 0.168 | 0.142 | |
| ROSUVASTATIN | |||||
| C10AA07 | PBS/RPBS | Plain | 12.992 | 21.752 | 29.449 |
| SURVEY | Plain | 0.033 | 0.043 | 0.055 | |
| SIMVASTATIN/strong> | |||||
| C10AA01 | PBS/RPBS | Plain | 24.689 | 21.938 | 19.795 |
| PBS/RPBS | Combination | 3.720 | 4.266 | 4.919 | |
| PBS/RPBS | Total | 28.409 | 26.204 | 24.714 | |
| SURVEY | Plain | 0.193 | 0.572 | 0.724 | |
| SURVEY | Combination | 0.009 | 0.008 | 0.010 | |
| SURVEY | Total | 0.202 | 0.580 | 0.734 | |
| FIBRATES | |||||
| FENOFIBRATE | |||||
| C10AB05 | PBS/RPBS | Plain | 1.161 | 1.383 | 1.594 |
| SURVEY | Plain | 0.017 | 0.019 | 0.021 | |
| GEMFIBROZIL | |||||
| C10AB04 | PBS/RPBS | Plain | 0.847 | 0.604 | 0.544 |
| SURVEY | Plain | 0.091 | 0.210 | 0.161 | |
| BILE ACID SEQUESTRANTS | |||||
| COLESTIPOL HYDROCHLORIDE | |||||
| C10AC02 | PBS/RPBS | Plain | 0.004 | 0.004 | 0.004 |
| COLESTYRAMINE | |||||
| C10AC01 | PBS/RPBS | Plain | 0.125 | 0.119 | 0.121 |
| SURVEY | Plain | 0.003 | 0.004 | 0.002 | |
| NICOTINIC ACID AND DERIVATIVES | |||||
| NICOTINIC ACID | |||||
| C10AD02 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| OTHER LIPID MODIFYING AGENTS | |||||
| EZETIMIBE | |||||
C10 - LIPID MODIFYING AGENTS PLAIN
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| CARDIOVASCULAR SYSTEM LIPID MODIFYING AGENTS PLAIN LIPID MODIFYING AGENTS PLAIN |
|||||
| C10AX09 | PBS/RPBS | Plain | 3.259 | 3.445 | 3.657 |
| PBS/RPBS | Combination | 1.917 | 2.185 | 2.571 | |
| PBS/RPBS | Total | 5.176 | 5.630 | 6.228 | |
| SURVEY | Plain | 0.020 | 0.018 | 0.014 | |
| SURVEY | Combination | 0.005 | 0.004 | 0.005 | |
| SURVEY | Total | 0.025 | 0.022 | 0.019 | |
D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| DERMATOLOGICALS ANTIFUNGALS FOR DERMATOLOGICAL USE ANTIFUNGALS FOR SYSTEMIC USE ANTIFUNGALS FOR SYSTEMIC USE |
|||||
| GRISEOFULVIN | |||||
| D01BA01 | PBS/RPBS | Plain | 0.055 | 0.070 | 0.105 |
| SURVEY | Plain | 0.049 | 0.055 | 0.071 | |
| TERBINAFINE | |||||
| D01BA02 | PBS/RPBS | Plain | 0.440 | 0.448 | 0.429 |
| SURVEY | Plain | 0.058 | 0.061 | 0.055 | |
D05 - ANTIPSORIATICS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| DERMATOLOGICALS ANTIPSORIATICS ANTIPSORIATICS FOR SYTEMIC USE PSORALENS FOR SYSTEMIC USE |
|||||
| METHOXSALEN | |||||
| D05BA02 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| RETINOIDS FOR TREATMENT OF PSORIASIS | |||||
| ACITRETIN | |||||
| D05BB02 | PBS/RPBS | Plain | 0.106 | 0.113 | 0.115 |
| SURVEY | Plain | 0.001 | 0.000 | 0.001 | |
D10 - ANTI-ACNE PREPARATIONS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| DERMATOLOGICALS ANTI-ACNE PREPARATIONS ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE RETINOIDS FOR TREATMENT OF ACNE |
|||||
| ISOTRETINOIN | |||||
| D10BA01 | PBS/RPBS | Plain | 0.740 | 0.779 | 0.817 |
| SURVEY | Plain | 0.018 | 0.018 | 0.017 | |
G01 - GYNAECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| GENITO URINARY SYSTEM AND SEX HORMONES GYNAECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS ANTIINFECTIVES/ANTISEPT.,EXCL. COMB. WITH CORTICOSTEROIDS ANTIBIOTICS |
|||||
| CLINDAMYCIN | |||||
| G01AA10 | SURVEY | Plain | 0.020 | 0.017 | 0.019 |
| NYSTATIN | |||||
| G01AA01 | PBS/RPBS | Plain | 0.001 | 0.001 | 0.001 |
| SURVEY | Plain | 0.011 | 0.012 | 0.009 | |
| IMIDAZOLE DERIVATIVES | |||||
| BUTOCONAZOLE | |||||
| G01AF15 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| CLOTRIMAZOLE | |||||
| G01AF02 | PBS/RPBS | Plain | 0.001 | 0.000 | 0.000 |
| SURVEY | Plain | 0.017 | 0.016 | 0.012 | |
| ECONAZOLE NITRATE | |||||
| G01AF05 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| MICONAZOLE NITRATE | |||||
| G01AF04 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
G02 - OTHER GYNAECOLOGICALS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| GENITO URINARY SYSTEM AND SEX HORMONES OTHER GYNAECOLOGICALS OXYTOCICS PROSTAGLANDINS |
|||||
| DINOPROSTONE | |||||
| G02AD02 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| OTHER GYNAECOLOGICALS | |||||
| PROLACTIN INHIBITORS | |||||
| BROMOCRIPTINE MESYLATE | |||||
| G02CB01 | PBS/RPBS | Plain | 0.003 | 0.003 | 0.003 |
| SURVEY | Plain | 0.006 | 0.004 | 0.004 | |
| CABERGOLINE | |||||
| G02CB03 | PBS/RPBS | Plain | 0.035 | 0.035 | 0.035 |
| SURVEY | Plain | 0.001 | 0.002 | 0.002 | |
| QUINAGOLIDE | |||||
| G02CB04 | PBS/RPBS | Plain | 0.003 | 0.003 | 0.004 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| GENITO URINARY SYSTEM AND SEX HORMONES SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE PROGESTOGENS |
|||||
| ETONOGESTREL | |||||
| G03AC08 | PBS/RPBS | Plain | 9.282 | 9.160 | 9.708 |
| SURVEY | Plain | 0.339 | 0.272 | 0.058 | |
| MEDROXYPROGESTERONE | |||||
| G03AC06 | PBS/RPBS | Plain | 1.262 | 1.263 | 1.262 |
| SURVEY | Plain | 1.537 | 1.399 | 1.294 | |
| EMERGENCY CONTRACEPTIVES | |||||
| LEVONORGESTREL | |||||
| G03AD01 | PBS/RPBS | Plain | 0.406 | 0.398 | 0.391 |
| SURVEY | Plain | 1.313 | 1.269 | 1.236 | |
| ANDROGENS | |||||
| 3-OXOANDROSTEN (4) DERIVATIVES | |||||
| TESTOSTERONE | |||||
| G03BA03 | PBS/RPBS | Plain | 0.631 | 0.711 | 0.766 |
| SURVEY | Plain | 0.178 | 0.161 | 0.167 | |
| 5-ANDROSTANON (3) DERIVATIVES | |||||
| MESTEROLONE | |||||
| G03BB01 | SURVEY | Plain | 0.001 | 0.001 | 0.001 |
| ESTROGENS | |||||
| NATURAL AND SEMISYNTHETIC ESTROGENS, PLAIN | |||||
| OESTRADIOL | |||||
| G03CA03 | PBS/RPBS | Plain | 1.510 | 1.485 | 1.469 |
| SURVEY | Plain | 1.351 | 1.244 | 1.208 | |
| OESTRADIOL VALERATE | |||||
| G03CA03 | PBS/RPBS | Plain | 0.333 | 0.503 | 0.679 |
| SURVEY | Plain | 0.413 | 0.468 | 0.506 | |
| OESTRIOL | |||||
| G03CA04 | PBS/RPBS | Plain | 2.221 | 2.225 | 2.242 |
| SURVEY | Plain | 1.005 | 0.995 | 0.976 | |
| OESTROGENS CONJUGATED | |||||
| G03CA57 | PBS/RPBS | Plain | 1.634 | 0.622 | 0.000 |
| SURVEY | Plain | 1.190 | 0.473 | 0.735 | |
| OESTRONE | |||||
| G03CA07 | PBS/RPBS | Plain | 0.337 | 0.000 | 0.000 |
| SURVEY | Plain | 0.262 | 0.005 | 0.000 | |
| OTHER ESTROGENS | |||||
| TIBOLONE | |||||
| G03CX01 | SURVEY | Plain | 0.973 | 0.970 | 0.943 |
| PROGESTOGENS | |||||
| PREGNEN (4) DERIVATIVES | |||||
| MEDROXYPROGESTERONE | |||||
G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| GENITO URINARY SYSTEM AND SEX HORMONES SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM PROGESTOGENS |
|||||
| G03DA02 | PBS/RPBS | Plain | 0.815 | 0.620 | 0.587 |
| SURVEY | Plain | 0.707 | 0.811 | 0.768 | |
| PROGESTERONE | |||||
| G03DA04 | SURVEY | Plain | 0.001 | 0.000 | 0.000 |
| PREGNADIEN DERIVATIVES | |||||
| DYDROGESTERONE | |||||
| G03DB01 | PBS/RPBS | Plain | 0.014 | 0.014 | 0.015 |
| SURVEY | Plain | 0.026 | 0.024 | 0.024 | |
| ESTREN DERIVATIVES | |||||
| NORETHISTERONE | |||||
| G03DC02 | PBS/RPBS | Plain | 0.564 | 0.547 | 0.283 |
| SURVEY | Plain | 0.020 | 0.017 | 0.288 | |
| PROGESTOGENS AND ESTROGENS IN COMBINATION | |||||
| PROGESTOGENS AND ESTROGENS,SEQUENTIAL PREPARATIONS | |||||
| OESTRADIOL with NORETHISTERONE ACETATE | |||||
| G03FB05 | SURVEY | Plain | 0.000 | 0.000 | 0.001 |
| GONADOTROPHINS AND OTHER OVULATION STIMULANTS | |||||
| GONADOTROPHINS | |||||
| CHORIOGONADOTROPIN ALFA | |||||
| G03GA08 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| FOLLITROPIN ALFA | |||||
| G03GA05 | PBS/RPBS | Plain | 0.005 | 0.005 | 0.006 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| FOLLITROPIN BETA | |||||
| G03GA06 | PBS/RPBS | Plain | 0.008 | 0.007 | 0.009 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| HUMAN CHORIONIC GONADOTROPHIN | |||||
| G03GA01 | PBS/RPBS | Plain | 0.021 | 0.023 | 0.024 |
| SURVEY | Plain | 0.003 | 0.002 | 0.003 | |
| OVULATION STIMULANTS, SYNTHETIC | |||||
| CLOMIPHENE CITRATE | |||||
| G03GB02 | PBS/RPBS | Plain | 0.266 | 0.147 | 0.255 |
| SURVEY | Plain | 0.018 | 0.110 | 0.017 | |
| ANTIANDROGENS | |||||
| ANTIANDROGENS, PLAIN PREPARATIONS | |||||
| CYPROTERONE ACETATE | |||||
| G03HA01 | PBS/RPBS | Plain | 0.408 | 0.376 | 0.342 |
| SURVEY | Plain | 0.006 | 0.009 | 0.005 | |
| OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM | |||||
| ANTIGONADOTROPINS AND SIMILAR AGENTS | |||||
| DANAZOL | |||||
| G03XA01 | PBS/RPBS | Plain | 0.008 | 0.007 | 0.006 |
G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| GENITO URINARY SYSTEM AND SEX HORMONES SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM |
|||||
| SURVEY | Plain | 0.000 | 0.000 | 0.001 | |
| GESTRINONE | |||||
| G03XA02 | PBS/RPBS | Plain | 0.001 | 0.000 | 0.001 |
| ANTIGONADOTROPINS AND SIMILAR AGENTS | |||||
| RALOXIFENE | |||||
| G03XC01 | PBS/RPBS | Plain | 1.045 | 0.922 | 0.821 |
| SURVEY | Plain | 0.058 | 0.045 | 0.036 | |
G04 - UROLOGICALS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| GENITO URINARY SYSTEM AND SEX HORMONES UROLOGICALS OTHER UROLOGICALS, INCL. ANTISPASMODICS URINARY ANTISPASMODICS |
|||||
| DARIFENACIN | |||||
| G04BD10 | SURVEY | Plain | 0.011 | 0.012 | 0.025 |
| OXYBUTYNIN | |||||
| G04BD04 | PBS/RPBS | Plain | 0.865 | 0.904 | 1.059 |
| SURVEY | Plain | 0.150 | 0.141 | 0.128 | |
| SOLIFENACIN | |||||
| G04BD08 | SURVEY | Plain | 0.476 | 0.559 | 0.611 |
| TOLTERODINE | |||||
| G04BD07 | SURVEY | Plain | 0.043 | 0.025 | 0.029 |
| DRUGS USED IN ERECTILE DYSFUNCTION | |||||
| ALPROSTADIL | |||||
| G04BE01 | PBS/RPBS | Plain | 0.002 | 0.002 | 0.002 |
| SURVEY | Plain | 0.043 | 0.034 | 0.038 | |
| SILDENAFIL | |||||
| G04BE03 | PBS/RPBS | Plain | 0.024 | 0.025 | 0.024 |
| SURVEY | Plain | 0.410 | 0.404 | 0.356 | |
| TADALAFIL | |||||
| G04BE08 | PBS/RPBS | Plain | 0.016 | 0.016 | 0.017 |
| SURVEY | Plain | 0.397 | 0.399 | 0.380 | |
| VARDENAFIL | |||||
| G04BE09 | SURVEY | Plain | 0.063 | 0.061 | 0.061 |
| DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY | |||||
| ALPHA-ADRENORECEPTOR ANTAGONISTS | |||||
| TAMSULOSIN | |||||
| G04CA02 | PBS/RPBS | Plain | 0.115 | 0.182 | 0.197 |
| SURVEY | Plain | 0.704 | 0.884 | 0.924 | |
| TERAZOSIN | |||||
| G04CA03 | PBS/RPBS | Plain | 0.007 | 0.005 | 0.005 |
| SURVEY | Plain | 0.011 | 0.014 | 0.011 | |
| TESTOSTERONE-5-ALPHA REDUCTASE INHIBITORS | |||||
| DUTASTERIDE | |||||
| G04CB02 | SURVEY | Plain | 0.000 | 0.001 | 0.041 |
| FINASTERIDE | |||||
| G04CB01 | PBS/RPBS | Plain | 0.057 | 0.057 | 0.055 |
| SURVEY | Plain | 0.181 | 0.192 | 0.170 | |
H01 - PITUITARY, HYPOTHALAMIC HORMONES AND ANALOGUES
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| SYSTEMIC HORMONAL PREP EXCL.SEX HORMONES PITUITARY, HYPOTHALAMIC HORMONES AND ANALOGUES ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES ACTH |
|||||
| TETRACOSACTRIN | |||||
| H01AA02 | PBS/RPBS | Plain | 0.001 | 0.001 | 0.000 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| SOMATROPIN AND ANALOGUES | |||||
| SOMATROPIN | |||||
| H01AC01 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| POSTERIOR PITUITARY LOBE HORMONES | |||||
| VASOPRESSIN AND ANALOGUES | |||||
| DESMOPRESSIN | |||||
| H01BA02 | PBS/RPBS | Plain | 0.273 | 0.268 | 0.266 |
| SURVEY | Plain | 0.011 | 0.010 | 0.010 | |
| OXYTOCIN AND ANALOGUES | |||||
| OXYTOCIN | |||||
| H01BB02 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| HYPOTHALAMIC HORMONES | |||||
| GONADOTROPHIN-RELEASING HORMONES | |||||
| NAFARELIN | |||||
| H01CA02 | PBS/RPBS | Plain | 0.005 | 0.005 | 0.004 |
| SURVEY | Plain | 0.009 | 0.010 | 0.010 | |
| ANTIGROWTH HORMONE | |||||
| LANREOTIDE | |||||
| H01CB03 | PBS/RPBS | Plain | 0.004 | 0.006 | 0.008 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| OCTREOTIDE | |||||
| H01CB02 | PBS/RPBS | Plain | 0.010 | 0.012 | 0.014 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| ANTI-GONADOTROPIN-RELEASING HORMONES | |||||
| GANIRELIX | |||||
| H01CC01 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
H02 - CORTICOSTEROIDS FOR SYSTEMIC USE
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| SYSTEMIC HORMONAL PREP EXCL.SEX HORMONES CORTICOSTEROIDS FOR SYSTEMIC USE CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN MINERALOCORTICOIDS |
|||||
| FLUDROCORTISONE ACETATE | |||||
| H02AA02 | PBS/RPBS | Plain | 0.431 | 0.429 | 0.509 |
| SURVEY | Plain | 0.222 | 0.239 | 0.182 | |
| GLUCOCORTICOIDS | |||||
| BETAMETHASONE | |||||
| H02AB01 | PBS/RPBS | Plain | 0.110 | 0.128 | 0.116 |
| SURVEY | Plain | 0.041 | 0.048 | 0.042 | |
| BUDESONIDE | |||||
| H02AB16 | SURVEY | Plain | 0.009 | 0.008 | 0.010 |
| CORTISONE | |||||
| H02AB10 | PBS/RPBS | Plain | 0.135 | 0.126 | 0.125 |
| SURVEY | Plain | 0.074 | 0.064 | 0.061 | |
| DEXAMETHASONE | |||||
| H02AB02 | PBS/RPBS | Plain | 0.806 | 0.822 | 0.777 |
| SURVEY | Plain | 0.253 | 0.253 | 0.265 | |
| HYDROCORTISONE | |||||
| H02AB09 | PBS/RPBS | Plain | 0.104 | 0.103 | 0.112 |
| SURVEY | Plain | 0.042 | 0.054 | 0.053 | |
| METHYLPREDNISOLONE | |||||
| H02AB04 | PBS/RPBS | Plain | 0.093 | 0.089 | 0.084 |
| SURVEY | Plain | 0.017 | 0.016 | 0.016 | |
| PREDNISOLONE | |||||
| H02AB06 | PBS/RPBS | Plain | 5.147 | 5.250 | 5.509 |
| SURVEY | Plain | 3.887 | 3.852 | 4.120 | |
| PREDNISONE | |||||
| H02AB07 | PBS/RPBS | Plain | 2.131 | 2.084 | 2.098 |
| SURVEY | Plain | 1.356 | 1.326 | 1.321 | |
| TRIAMCINOLONE ACETONIDE | |||||
| H02AB08 | PBS/RPBS | Plain | 0.015 | 0.003 | 0.005 |
| SURVEY | Plain | 0.014 | 0.003 | 0.004 | |
H03 - THYROID THERAPY
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| SYSTEMIC HORMONAL PREP EXCL.SEX HORMONES THYROID THERAPY THYROID PREPARATIONS THYROID HORMONES |
|||||
| LEVOTHYROXINE SODIUM | |||||
| H03AA01 | PBS/RPBS | Plain | 10.243 | 10.220 | 10.360 |
| SURVEY | Plain | 6.416 | 6.094 | 5.915 | |
| LIOTHYRONINE | |||||
| H03AA02 | PBS/RPBS | Plain | 0.046 | 0.047 | 0.049 |
| SURVEY | Plain | 0.004 | 0.003 | 0.003 | |
| ANTITHYROID PREPARATIONS | |||||
| THIOURACILS | |||||
| PROPYLTHIOURACIL | |||||
| H03BA02 | PBS/RPBS | Plain | 0.211 | 0.203 | 0.201 |
| SURVEY | Plain | 0.007 | 0.007 | 0.005 | |
| SULPHUR-CONTAINING IMIDAZOLE DERIVATIVES | |||||
| CARBIMAZOLE | |||||
| H03BB01 | PBS/RPBS | Plain | 0.370 | 0.380 | 0.420 |
| SURVEY | Plain | 0.264 | 0.263 | 0.287 | |
H04 - PANCREATIC HORMONES
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| SYSTEMIC HORMONAL PREP EXCL.SEX HORMONES PANCREATIC HORMONES GLYCOGENOLYTIC HORMONES GLYCOGENOLYTIC HORMONES |
|||||
| GLUCAGON HYDROCHLORIDE | |||||
| H04AA01 | PBS/RPBS | Plain | 0.006 | 0.006 | 0.006 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
H05 - CALCIUM HOMEOSTASIS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| SYSTEMIC HORMONAL PREP EXCL.SEX HORMONES CALCIUM HOMEOSTASIS PARATHYROID HORMONES AND ANALOGUES PARATHYROID HORMONES AND ANALOGUES |
|||||
| TERIPARATIDE (RBE) | |||||
| H05AA02 | PBS/RPBS | Plain | 0.000 | 0.005 | 0.020 |
| SURVEY | Plain | 0.000 | 0.002 | 0.004 | |
| ANTI-PARATHYROID AGENTS | |||||
| CALCITONIN PREPARATIONS | |||||
| CALCITONIN (SALMON SYNTHETIC) | |||||
| H05BA01 | PBS/RPBS | Plain | 0.001 | 0.000 | 0.000 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| OTHER ANTI-PARATHYROID AGENTS | |||||
| CINACALCET | |||||
| H05BX01 | PBS/RPBS | Plain | 0.006 | 0.024 | 0.036 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
J01 - ANTIBACTERIALS FOR SYSTEMIC USE
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| GENERAL ANTIINFECTIVES FOR SYSTEMIC USE ANTIBACTERIALS FOR SYSTEMIC USE TETRACYCLINES TETRACYCLINES |
|||||
| DOXYCYCLINE | |||||
| J01AA02 | PBS/RPBS | Plain | 1.132 | 1.101 | 1.134 |
| SURVEY | Plain | 1.541 | 1.416 | 1.414 | |
| MINOCYCLINE | |||||
| J01AA08 | PBS/RPBS | Plain | 0.240 | 0.232 | 0.233 |
| SURVEY | Plain | 0.581 | 0.517 | 0.493 | |
| BETA-LACTAM ANTIBACTERIALS,PENICILLINS | |||||
| PENICILLINS WITH EXTENDED SPECTRUM | |||||
| AMOXYCILLIN | |||||
| J01CA04 | PBS/RPBS | Plain | 2.701 | 2.567 | 2.621 |
| SURVEY | Plain | 4.058 | 3.615 | 3.641 | |
| SURVEY | Combination | 0.000 | 0.000 | 0.000 | |
| SURVEY | Total | 4.058 | 3.615 | 3.641 | |
| AMPICILLIN | |||||
| J01CA01 | PBS/RPBS | Plain | 0.004 | 0.003 | 0.003 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| BETA-LACTAMASE SENSITIVE PENICILLINS | |||||
| BENZATHINE PENICILLIN | |||||
| J01CE08 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| BENZATHINE PHENOXYMETHYLPENICILLIN | |||||
| J01CE10 | PBS/RPBS | Plain | 0.015 | 0.017 | 0.019 |
| SURVEY | Plain | 0.031 | 0.033 | 0.039 | |
| BENZYLPENICILLIN | |||||
| J01CE01 | PBS/RPBS | Plain | 0.006 | 0.006 | 0.006 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| PHENOXYMETHYLPENICILLIN | |||||
| J01CE02 | PBS/RPBS | Plain | 0.179 | 0.188 | 0.190 |
| SURVEY | Plain | 0.485 | 0.450 | 0.454 | |
| PROCAINE PENICILLIN | |||||
| J01CE09 | PBS/RPBS | Plain | 0.019 | 0.017 | 0.015 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| BETA-LACTAMASE RESISTANT PENICILLINS | |||||
| DICLOXACILLIN | |||||
| J01CF01 | PBS/RPBS | Plain | 0.154 | 0.144 | 0.144 |
| SURVEY | Plain | 0.170 | 0.149 | 0.146 | |
| FLUCLOXACILLIN | |||||
| J01CF05 | PBS/RPBS | Plain | 0.191 | 0.198 | 0.211 |
| SURVEY | Plain | 0.201 | 0.200 | 0.215 | |
| COMBINATIONS OF PENICILLINS, INCL.BETA-LACTAMASE INHIBITORS | |||||
| AMOXYCILLIN with CLAVULANIC ACID | |||||
J01 - ANTIBACTERIALS FOR SYSTEMIC USE
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| GENERAL ANTIINFECTIVES FOR SYSTEMIC USE ANTIBACTERIALS FOR SYSTEMIC USE BETA-LACTAM ANTIBACTERIALS,PENICILLINS |
|||||
| J01CR02 | PBS/RPBS | Plain | 1.801 | 1.764 | 1.874 |
| SURVEY | Plain | 2.395 | 2.135 | 2.160 | |
| TICARCILLIN with CLAVULANIC ACID | |||||
| J01CR03 | PBS/RPBS | Plain | 0.008 | 0.008 | 0.009 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| OTHER BETA-LACTAM ANTIBACTERIALS | |||||
| FIRST-GENERATION CEPHALOSPORINS | |||||
| CEFALEXIN | |||||
| J01DB01 | PBS/RPBS | Plain | 1.450 | 1.466 | 1.546 |
| SURVEY | Plain | 1.290 | 1.229 | 1.250 | |
| CEFALOTHIN | |||||
| J01DB03 | PBS/RPBS | Plain | 0.015 | 0.013 | 0.009 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| CEPHAZOLIN | |||||
| J01DB04 | PBS/RPBS | Plain | 0.009 | 0.010 | 0.013 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| SECOND-GENERATION CEPHALOSPORINS | |||||
| CEFACLOR | |||||
| J01DC04 | PBS/RPBS | Plain | 0.233 | 0.201 | 0.188 |
| SURVEY | Plain | 0.352 | 0.278 | 0.268 | |
| CEFOXITIN | |||||
| J01DC01 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| CEFUROXIME | |||||
| J01DC02 | PBS/RPBS | Plain | 0.055 | 0.053 | 0.054 |
| SURVEY | Plain | 0.058 | 0.050 | 0.050 | |
| THIRD-GENERATION CEPHALOSPORINS | |||||
| CEFOTAXIME | |||||
| J01DD01 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| CEFTAZIDIME | |||||
| J01DD02 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| CEFTRIAXONE | |||||
| J01DD04 | PBS/RPBS | Plain | 0.018 | 0.018 | 0.018 |
| SURVEY | Plain | 0.001 | 0.001 | 0.001 | |
| FOUTH-GENERATION CEPHALOSPORINS | |||||
| CEFEPIME | |||||
| J01DE01 | PBS/RPBS | Plain | 0.000 | 0.001 | 0.001 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| SULFONAMIDES AND TRIMETHOPRIM | |||||
| TRIMETHOPRIM AND DERIVATIVES | |||||
| TRIMETHOPRIM | |||||
| J01EA01 | PBS/RPBS | Plain | 0.354 | 0.354 | 0.361 |
J01 - ANTIBACTERIALS FOR SYSTEMIC USE
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| GENERAL ANTIINFECTIVES FOR SYSTEMIC USE ANTIBACTERIALS FOR SYSTEMIC USE SULFONAMIDES AND TRIMETHOPRIM |
|||||
| SURVEY | Plain | 0.215 | 0.208 | 0.202 | |
| MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS | |||||
| MACROLIDES | |||||
| AZITHROMYCIN | |||||
| J01FA10 | PBS/RPBS | Plain | 0.013 | 0.016 | 0.019 |
| SURVEY | Plain | 0.076 | 0.091 | 0.109 | |
| CLARITHROMYCIN | |||||
| J01FA09 | PBS/RPBS | Plain | 0.328 | 0.364 | 0.398 |
| SURVEY | Plain | 0.414 | 0.444 | 0.469 | |
| SURVEY | Combination | 0.000 | 0.000 | 0.000 | |
| SURVEY | Total | 0.414 | 0.444 | 0.469 | |
| ERYTHROMYCIN | |||||
| J01FA01 | PBS/RPBS | Plain | 0.406 | 0.436 | 0.443 |
| SURVEY | Plain | 0.625 | 0.644 | 0.641 | |
| ROXITHROMYCIN | |||||
| J01FA06 | PBS/RPBS | Plain | 0.801 | 0.761 | 0.758 |
| SURVEY | Plain | 0.867 | 0.764 | 0.720 | |
| LINCOSAMIDES | |||||
| CLINDAMYCIN | |||||
| J01FF01 | PBS/RPBS | Plain | 0.069 | 0.076 | 0.085 |
| SURVEY | Plain | 0.045 | 0.043 | 0.043 | |
| LINCOMYCIN | |||||
| J01FF02 | PBS/RPBS | Plain | 0.001 | 0.001 | 0.001 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| AMINOGLYCOSIDE ANTIBACTERIALS | |||||
| OTHER AMINOGLYCOSIDES | |||||
| GENTAMICIN SULPHATE | |||||
| J01GB03 | PBS/RPBS | Plain | 0.008 | 0.008 | 0.007 |
| SURVEY | Plain | 0.001 | 0.001 | 0.001 | |
| TOBRAMYCIN | |||||
| J01GB01 | PBS/RPBS | Plain | 0.003 | 0.003 | 0.003 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| QUINOLONE ANTIBACTERIALS | |||||
| FLUOROQUINOLONES | |||||
| CIPROFLOXACIN | |||||
| J01MA02 | PBS/RPBS | Plain | 0.260 | 0.256 | 0.266 |
| SURVEY | Plain | 0.029 | 0.032 | 0.038 | |
| MOXIFLOXACIN | |||||
| J01MA14 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| SURVEY | Plain | 0.001 | 0.002 | 0.003 | |
| NORFLOXACIN | |||||
| J01MA06 | PBS/RPBS | Plain | 0.152 | 0.146 | 0.146 |
J01 - ANTIBACTERIALS FOR SYSTEMIC USE
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| GENERAL ANTIINFECTIVES FOR SYSTEMIC USE ANTIBACTERIALS FOR SYSTEMIC USE QUINOLONE ANTIBACTERIALS |
|||||
| SURVEY | Plain | 0.120 | 0.115 | 0.117 | |
| OTHER ANTIBACTERIALS | |||||
| GLYCOPEPTIDE ANTIBACTERIALS | |||||
| VANCOMYCIN | |||||
| J01XA01 | PBS/RPBS | Plain | 0.008 | 0.007 | 0.007 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| STEROID ANTIBACTERIALS | |||||
| FUSIDIC ACID | |||||
| J01XC01 | PBS/RPBS | Plain | 0.034 | 0.034 | 0.034 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| IMIDAZOLE DERIVATIVES | |||||
| METRONIDAZOLE | |||||
| J01XD01 | PBS/RPBS | Plain | 0.006 | 0.003 | 0.003 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| NITROFURAN DERIVATIVES | |||||
| NITROFURANTOIN | |||||
| J01XE01 | PBS/RPBS | Plain | 0.183 | 0.183 | 0.189 |
| SURVEY | Plain | 0.051 | 0.048 | 0.048 | |
| OTHER ANTIBACTERIALS | |||||
| HEXAMINE HIPPURATE | |||||
| J01XX05 | PBS/RPBS | Plain | 0.475 | 0.496 | 0.536 |
| SURVEY | Plain | 0.002 | 0.002 | 0.002 | |
J02 - ANTIMYCOTICS FOR SYSTEMIC USE
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| GENERAL ANTIINFECTIVES FOR SYSTEMIC USE ANTIMYCOTICS FOR SYSTEMIC USE ANTIMYCOTICS FOR SYSTEMIC USE ANTIBIOTICS |
|||||
| AMPHOTERICIN | |||||
| J02AA01 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| IMIDAZOLE DERIVATIVES | |||||
| KETOCONAZOLE | |||||
| J02AB02 | PBS/RPBS | Plain | 0.083 | 0.081 | 0.073 |
| SURVEY | Plain | 0.060 | 0.053 | 0.050 | |
| TRIAZOLE DERIVATIVES | |||||
| FLUCONAZOLE | |||||
| J02AC01 | PBS/RPBS | Plain | 0.058 | 0.060 | 0.067 |
| SURVEY | Plain | 0.005 | 0.004 | 0.004 | |
| ITRACONAZOLE | |||||
| J02AC02 | PBS/RPBS | Plain | 0.028 | 0.027 | 0.029 |
| SURVEY | Plain | 0.006 | 0.005 | 0.009 | |
| POSACONAZOLE | |||||
| J02AC04 | PBS/RPBS | Plain | 0.000 | 0.002 | 0.004 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| VORICONAZOLE | |||||
| J02AC03 | PBS/RPBS | Plain | 0.000 | 0.005 | 0.010 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
J04 - ANTIMYCOBACTERIALS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| GENERAL ANTIINFECTIVES FOR SYSTEMIC USE ANTIMYCOBACTERIALS DRUGS FOR TREATMENT OF TUBERCULOSIS ANTIBIOTICS |
|||||
| RIFABUTIN | |||||
| J04AB04 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| SURVEY | Plain | 0.001 | 0.001 | 0.000 | |
| RIFAMPICIN | |||||
| J04AB02 | PBS/RPBS | Plain | 0.007 | 0.007 | 0.007 |
| SURVEY | Plain | 0.014 | 0.013 | 0.012 | |
| HYDRAZIDES | |||||
| ISONIAZID | |||||
| J04AC01 | PBS/RPBS | Plain | 0.004 | 0.004 | 0.005 |
| SURVEY | Plain | 0.002 | 0.002 | 0.003 | |
| DRUGS FOR TREATMENT OF LEPRA | |||||
| DRUGS FOR TREATMENT OF LEPRA | |||||
| DAPSONE | |||||
| J04BA02 | PBS/RPBS | Plain | 0.081 | 0.083 | 0.089 |
| SURVEY | Plain | 0.001 | 0.001 | 0.000 | |
J05 - ANTIVIRALS FOR SYSTEMIC USE
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| GENERAL ANTIINFECTIVES FOR SYSTEMIC USE ANTIVIRALS FOR SYSTEMIC USE DIRECT ACTING ANTIVIRALS NUCLEOSIDES AND NUCLEOTIDES EXCL. REVERSE TRANSCRIPTASE INHIBITORS |
|||||
| ACICLOVIR | |||||
| J05AB01 | PBS/RPBS | Plain | 0.025 | 0.024 | 0.023 |
| SURVEY | Plain | 0.004 | 0.004 | 0.004 | |
| FAMCICLOVIR | |||||
| J05AB09 | PBS/RPBS | Plain | 0.235 | 0.256 | 0.268 |
| SURVEY | Plain | 0.016 | 0.024 | 0.025 | |
| GANCICLOVIR | |||||
| J05AB06 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| VALACICLOVIR | |||||
| J05AB11 | PBS/RPBS | Plain | 0.244 | 0.253 | 0.265 |
| SURVEY | Plain | 0.005 | 0.008 | 0.009 | |
| VALGANCICLOVIR | |||||
| J05AB14 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.001 |
| PHOSPHONIC ACID DERIVATIVES | |||||
| FOSCARNET | |||||
| J05AD01 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| PROTEINASE INHIBITORS | |||||
| ATAZANAVIR | |||||
| J05AE08 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| SURVEY | Plain | 0.003 | 0.000 | 0.000 | |
| DARUNAVIR | |||||
| J05AE10 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| FOSAMPRENAVIR | |||||
| J05AE07 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| INDINAVIR | |||||
| J05AE02 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| RITONAVIR | |||||
| J05AE03 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| SAQUINAVIR | |||||
| J05AE01 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS | |||||
| ADEFOVIR DIPIVOXIL | |||||
| J05AF08 | PBS/RPBS | Plain | 0.022 | 0.025 | 0.016 |
| SURVEY | Plain | 0.001 | 0.001 | 0.002 | |
| DIDANOSINE | |||||
| J05AF02 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| SURVEY | Plain | 0.001 | 0.001 | 0.001 | |
| ENTECAVIR | |||||
| J05AF10 | PBS/RPBS | Plain | 0.050 | 0.073 | 0.094 |
| SURVEY | Plain | 0.002 | 0.001 | 0.002 | |
| LAMIVUDINE | |||||
J05 - ANTIVIRALS FOR SYSTEMIC USE
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| GENERAL ANTIINFECTIVES FOR SYSTEMIC USE ANTIVIRALS FOR SYSTEMIC USE DIRECT ACTING ANTIVIRALS |
|||||
| J05AF05 | PBS/RPBS | Plain | 0.011 | 0.011 | 0.009 |
| SURVEY | Plain | 0.001 | 0.002 | 0.002 | |
| STAVUDINE | |||||
| J05AF04 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| TELBIVUDINE | |||||
| J05AF11 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| TENOFOVIR | |||||
| J05AF07 | PBS/RPBS | Plain | 0.000 | 0.001 | 0.025 |
| SURVEY | Plain | 0.000 | 0.002 | 0.020 | |
| ZIDOVUDINE | |||||
| J05AF01 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | |||||
| EFAVIRENZ | |||||
| J05AG03 | PBS/RPBS | Plain | 0.001 | 0.001 | 0.001 |
| SURVEY | Plain | 0.001 | 0.000 | 0.000 | |
| ETRAVIRINE | |||||
| J05AG04 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| NEVIRAPINE | |||||
| J05AG01 | PBS/RPBS | Plain | 0.001 | 0.001 | 0.001 |
| SURVEY | Plain | 0.015 | 0.019 | 0.023 | |
| NEURAMINIDASE INHIBITORS | |||||
| OSELTAMIVIR | |||||
| J05AH02 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| ZANAMIVIR | |||||
| J05AH01 | SURVEY | Plain | 0.001 | 0.005 | 0.001 |
| OTHER ANTIVIRALS | |||||
| RALTEGRAVIR | |||||
| J05AX08 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
L02 - ENDOCRINE THERAPY
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS ENDOCRINE THERAPY HORMONES AND RELATED AGENTS PROGESTOGENS |
|||||
| MEDROXYPROGESTERONE | |||||
| L02AB02 | PBS/RPBS | Plain | 0.007 | 0.005 | 0.005 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| MEGESTROL | |||||
| L02AB01 | PBS/RPBS | Plain | 0.006 | 0.005 | 0.005 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| GONADOTROPHIN RELEASING HORMONE ANALOGUES | |||||
| GOSERELIN | |||||
| L02AE03 | PBS/RPBS | Plain | 0.596 | 0.590 | 0.589 |
| SURVEY | Plain | 0.003 | 0.004 | 0.003 | |
| LEUPRORELIN ACETATE | |||||
| L02AE02 | PBS/RPBS | Plain | 0.793 | 0.830 | 0.819 |
| SURVEY | Plain | 0.020 | 0.002 | 0.003 | |
| TRIPTORELIN | |||||
| L02AE04 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.001 |
| HORMONE ANTAGONISTS AND RELATED AGENTS | |||||
| ANTI-ESTROGENS | |||||
| FULVESTRANT | |||||
| L02BA03 | SURVEY | Plain | 0.000 | 0.001 | 0.000 |
| TAMOXIFEN | |||||
| L02BA01 | PBS/RPBS | Plain | 0.975 | 0.910 | 0.879 |
| SURVEY | Plain | 0.007 | 0.009 | 0.010 | |
| TOREMIFENE | |||||
| L02BA02 | PBS/RPBS | Plain | 0.010 | 0.008 | 0.006 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| ANTI-ANDROGENS | |||||
| BICALUTAMIDE | |||||
| L02BB03 | PBS/RPBS | Plain | 0.128 | 0.127 | 0.125 |
| SURVEY | Plain | 0.002 | 0.002 | 0.001 | |
| FLUTAMIDE | |||||
| L02BB01 | PBS/RPBS | Plain | 0.012 | 0.011 | 0.009 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| NILUTAMIDE | |||||
| L02BB02 | PBS/RPBS | Plain | 0.092 | 0.090 | 0.089 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| ENZYME INHIBITORS | |||||
| AMINOGLUTETHIMIDE | |||||
| L02BG01 | PBS/RPBS | Plain | 0.001 | 0.000 | 0.000 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| ANASTROZOLE | |||||
| L02BG03 | PBS/RPBS | Plain | 0.731 | 0.773 | 0.793 |
L02 - ENDOCRINE THERAPY
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS ENDOCRINE THERAPY HORMONE ANTAGONISTS AND RELATED AGENTS |
|||||
| SURVEY | Plain | 0.002 | 0.001 | 0.003 | |
| EXEMESTANE | |||||
| L02BG06 | PBS/RPBS | Plain | 0.070 | 0.077 | 0.082 |
| SURVEY | Plain | 0.000 | 0.000 | 0.001 | |
| LETROZOLE | |||||
| L02BG04 | PBS/RPBS | Plain | 0.347 | 0.409 | 0.466 |
| SURVEY | Plain | 0.003 | 0.006 | 0.005 | |
| OTHER HORMONE ANTAGONISTS AND RELATED AGENTS | |||||
| DEGARELIX | |||||
| L02BX02 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
L03 - IMMUNOSTIMULANTS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS IMMUNOSTIMULANTS CYTOKINES AND IMMUNOMODULATORS COLONY STIMULATING FACTORS |
|||||
| FILGRASTIM | |||||
| L03AA02 | PBS/RPBS | Plain | 0.006 | 0.006 | 0.006 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| LENOGRASTIM | |||||
| L03AA10 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| PEGFILGRASTIM | |||||
| L03AA13 | PBS/RPBS | Plain | 0.038 | 0.041 | 0.042 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| INTERFERONS | |||||
| INTERFERON BETA-1a | |||||
| L03AB07 | PBS/RPBS | Plain | 0.347 | 0.347 | 0.366 |
| SURVEY | Plain | 0.003 | 0.003 | 0.001 | |
| INTERFERON BETA-1b | |||||
| L03AB08 | PBS/RPBS | Plain | 0.126 | 0.122 | 0.118 |
| SURVEY | Plain | 0.000 | 0.001 | 0.001 | |
| INTERFERON-ALFA-2a | |||||
| L03AB04 | PBS/RPBS | Plain | 0.007 | 0.006 | 0.006 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| INTERFERON-ALFA-2b | |||||
| L03AB05 | PBS/RPBS | Plain | 0.004 | 0.003 | 0.004 |
| INTERFERON-GAMMA | |||||
| L03AB03 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| PEGINTERFERON ALFA-2a | |||||
| L03AB11 | PBS/RPBS | Plain | 0.001 | 0.001 | 0.001 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| PEGINTERFERON ALFA-2b | |||||
| L03AB10 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| OTHER IMMUNOSTIMULANTS | |||||
| GLATIRAMER ACETATE | |||||
| L03AX13 | PBS/RPBS | Plain | 0.071 | 0.079 | 0.087 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
L04 - IMMUNOSUPPRESSANTS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS IMMUNOSUPPRESSANTS IMMUNOSUPPRESSANTS SELECTIVE IMMUNOSUPPRESSANTS |
|||||
| ABATACEPT | |||||
| L04AA24 | PBS/RPBS | Plain | 0.005 | 0.015 | 0.020 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| EFALIZUMAB | |||||
| L04AA21 | PBS/RPBS | Plain | 0.033 | 0.009 | 0.000 |
| SURVEY | Plain | 0.001 | 0.000 | 0.000 | |
| EVEROLIMUS | |||||
| L04AA18 | PBS/RPBS | Plain | 0.003 | 0.004 | 0.006 |
| LEFLUNOMIDE | |||||
| L04AA13 | PBS/RPBS | Plain | 0.535 | 0.560 | 0.568 |
| SURVEY | Plain | 0.002 | 0.001 | 0.001 | |
| MYCOPHENOLIC ACID | |||||
| L04AA06 | PBS/RPBS | Plain | 0.042 | 0.051 | 0.059 |
| SURVEY | Plain | 0.002 | 0.003 | 0.003 | |
| NATALIZUMAB | |||||
| L04AA23 | PBS/RPBS | Plain | 0.005 | 0.012 | 0.015 |
| SIROLIMUS | |||||
| L04AA10 | PBS/RPBS | Plain | 0.004 | 0.004 | 0.004 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| TUMOR NECROSIS FACTOR ALPHA INHIBITORS | |||||
| ADALIMUMAB | |||||
| L04AB04 | PBS/RPBS | Plain | 0.173 | 0.260 | 0.318 |
| SURVEY | Plain | 0.000 | 0.000 | 0.001 | |
| CERTOLIZUMAB PEGOL | |||||
| L04AB05 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.001 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| ETANERCEPT | |||||
| L04AB01 | PBS/RPBS | Plain | 0.184 | 0.217 | 0.246 |
| SURVEY | Plain | 0.001 | 0.001 | 0.000 | |
| GOLIMUMAB | |||||
| L04AB06 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.012 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| INFLIXIMAB | |||||
| L04AB02 | PBS/RPBS | Plain | 0.150 | 0.187 | 0.162 |
| SURVEY | Plain | 0.000 | 0.000 | 0.001 | |
| INTERLEUKIN INHIBITORS | |||||
| ANAKINRA | |||||
| L04AC03 | PBS/RPBS | Plain | 0.001 | 0.001 | 0.001 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| TOCILIZUMAB | |||||
| L04AC07 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.007 |
L04 - IMMUNOSUPPRESSANTS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS IMMUNOSUPPRESSANTS IMMUNOSUPPRESSANTS |
|||||
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| USTEKINUMAB | |||||
| L04AC05 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.020 |
| CALCINEURIN INHIBITORS | |||||
| CYCLOSPORIN | |||||
| L04AD01 | PBS/RPBS | Plain | 0.077 | 0.078 | 0.082 |
| SURVEY | Plain | 0.002 | 0.004 | 0.005 | |
| TACROLIMUS | |||||
| L04AD02 | PBS/RPBS | Plain | 0.035 | 0.041 | 0.051 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| OTHER IMMUNOSUPPRESSANTS | |||||
| AZATHIOPRINE | |||||
| L04AX01 | PBS/RPBS | Plain | 0.547 | 0.567 | 0.600 |
| SURVEY | Plain | 0.002 | 0.004 | 0.004 | |
| LENALIDOMIDE | |||||
| L04AX04 | PBS/RPBS | Plain | 0.000 | 0.002 | 0.016 |
| THALIDOMIDE | |||||
| L04AX02 | PBS/RPBS | Plain | 0.009 | 0.010 | 0.014 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| MUSCULO-SKELETAL SYSTEM ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS ANTIINFLAMMATORY/ANTIRHEUMATIC PRODDUCTS,NON-STEROIDS ACETIC ACID DERIVATIVES AND RELATED SUBSTANCES |
|||||
| DICLOFENAC | |||||
| M01AB05 | PBS/RPBS | Plain | 2.116 | 1.980 | 1.767 |
| PBS/RPBS | Combination | 0.003 | 0.003 | 0.002 | |
| PBS/RPBS | Total | 2.119 | 1.983 | 1.769 | |
| SURVEY | Plain | 1.845 | 1.713 | 1.535 | |
| SURVEY | Combination | 0.002 | 0.002 | 0.003 | |
| SURVEY | Total | 1.847 | 1.715 | 1.538 | |
| INDOMETHACIN | |||||
| M01AB01 | PBS/RPBS | Plain | 0.641 | 0.614 | 0.595 |
| SURVEY | Plain | 0.628 | 0.577 | 0.543 | |
| KETOROLAC | |||||
| M01AB15 | SURVEY | Plain | 0.003 | 0.002 | 0.002 |
| SULINDAC | |||||
| M01AB02 | PBS/RPBS | Plain | 0.040 | 0.033 | 0.030 |
| SURVEY | Plain | 0.011 | 0.012 | 0.011 | |
| OXICAMS | |||||
| MELOXICAM | |||||
| M01AC06 | PBS/RPBS | Plain | 5.683 | 5.561 | 5.415 |
| SURVEY | Plain | 2.219 | 2.209 | 2.184 | |
| PIROXICAM | |||||
| M01AC01 | PBS/RPBS | Plain | 0.562 | 0.478 | 0.419 |
| SURVEY | Plain | 0.317 | 0.264 | 0.233 | |
| PROPIONIC ACID DERIVATIVES | |||||
| IBUPROFEN | |||||
| M01AE01 | PBS/RPBS | Plain | 0.761 | 0.706 | 0.658 |
| SURVEY | Plain | 0.412 | 0.385 | 0.353 | |
| SURVEY | Combination | 0.061 | 0.068 | 0.094 | |
| SURVEY | Total | 0.473 | 0.453 | 0.447 | |
| KETOPROFEN | |||||
| M01AE03 | PBS/RPBS | Plain | 0.596 | 0.518 | 0.453 |
| SURVEY | Plain | 0.273 | 0.238 | 0.219 | |
| NAPROXEN | |||||
| M01AE02 | PBS/RPBS | Plain | 2.265 | 2.092 | 1.984 |
| SURVEY | Plain | 1.853 | 1.677 | 1.583 | |
| TIAPROFENIC ACID | |||||
| M01AE11 | PBS/RPBS | Plain | 0.037 | 0.030 | 0.026 |
| SURVEY | Plain | 0.013 | 0.008 | 0.008 | |
| FENAMATES | |||||
| MEFENAMIC ACID | |||||
| M01AG01 | PBS/RPBS | Plain | 0.037 | 0.037 | 0.037 |
| SURVEY | Plain | 0.034 | 0.035 | 0.035 | |
M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| MUSCULO-SKELETAL SYSTEM ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS ANTIINFLAMMATORY/ANTIRHEUMATIC PRODDUCTS,NON-STEROIDS COXIBS |
|||||
| CELECOXIB | |||||
| M01AH01 | PBS/RPBS | Plain | 5.579 | 4.690 | 4.383 |
| SURVEY | Plain | 0.995 | 1.428 | 1.365 | |
| ETORICOXIB | |||||
| M01AH05 | SURVEY | Plain | 0.000 | 0.000 | 0.032 |
| SPECIFIC ANTIRHEUMATIC AGENTS | |||||
| GOLD PREPARATIONS | |||||
| AURANOFIN | |||||
| M01CB03 | PBS/RPBS | Plain | 0.013 | 0.011 | 0.010 |
| SODIUM AUROTHIOMALATE | |||||
| M01CB01 | PBS/RPBS | Plain | 0.051 | 0.045 | 0.039 |
| SURVEY | Plain | 0.000 | 0.001 | 0.000 | |
| PENICILLAMINE | |||||
| PENICILLAMINE | |||||
| M01CC01 | PBS/RPBS | Plain | 0.034 | 0.031 | 0.029 |
| SURVEY | Plain | 0.002 | 0.001 | 0.001 | |
M03 - MUSCLE RELAXANTS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| MUSCULO-SKELETAL SYSTEM MUSCLE RELAXANTS MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS ETHERS, CHEMICALLY CLOSE TO ANTIHISTAMINES |
|||||
| ORPHENADRINE CITRATE | |||||
| M03BC01 | SURVEY | Plain | 0.064 | 0.057 | 0.072 |
| ORPHENADRINE CITRATE with PARACETAMOL | |||||
| M03BC51 | SURVEY | Plain | 0.010 | 0.008 | 0.022 |
| OTHER CENTRALLY ACTING AGENTS | |||||
| BACLOFEN | |||||
| M03BX01 | PBS/RPBS | Plain | 0.590 | 0.555 | 0.571 |
| SURVEY | Plain | 0.005 | 0.047 | 0.050 | |
| MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS | |||||
| DANTROLENE AND DERIVATIVES | |||||
| DANTROLENE SODIUM | |||||
| M03CA01 | PBS/RPBS | Plain | 0.033 | 0.032 | 0.033 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
M04 - ANTIGOUT PREPARATIONS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| MUSCULO-SKELETAL SYSTEM ANTIGOUT PREPARATIONS ANTIGOUT PREPARATIONS PREPARATIONS INHIBITING URIC ACID PRODUCTION |
|||||
| ALLOPURINOL | |||||
| M04AA01 | PBS/RPBS | Plain | 4.747 | 4.558 | 4.530 |
| SURVEY | Plain | 2.033 | 1.879 | 1.789 | |
| PREPARATIONS INCREASING URIC ACID EXCRETION | |||||
| PROBENECID | |||||
| M04AB01 | PBS/RPBS | Plain | 0.114 | 0.112 | 0.112 |
| SURVEY | Plain | 0.002 | 0.001 | 0.001 | |
| PREPARATIONS WITH NO EFFECT ON URIC ACID METABOLISM | |||||
| COLCHICINE | |||||
| M04AC01 | PBS/RPBS | Plain | 1.072 | 1.025 | 1.966 |
| SURVEY | Plain | 0.537 | 0.510 | 0.824 | |
M05 - DRUGS FOR TREATMENT OF BONE DISEASES
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| MUSCULO-SKELETAL SYSTEM DRUGS FOR TREATMENT OF BONE DISEASES DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION BISPHOSPHONATES |
|||||
| ALENDRONIC ACID | |||||
| M05BA04 | PBS/RPBS | Plain | 4.537 | 3.358 | 2.543 |
| PBS/RPBS | Combination | 2.973 | 3.253 | 3.330 | |
| PBS/RPBS | Total | 7.510 | 6.611 | 5.873 | |
| SURVEY | Plain | 0.170 | 0.118 | 0.084 | |
| SURVEY | Combination | 0.068 | 0.069 | 0.059 | |
| SURVEY | Total | 0.238 | 0.187 | 0.143 | |
| CLODRONIC ACID | |||||
| M05BA02 | PBS/RPBS | Plain | 0.064 | 0.054 | 0.047 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| DISODIUM ETIDRONATE | |||||
| M05BA01 | PBS/RPBS | Plain | 0.001 | 0.001 | 0.002 |
| PBS/RPBS | Combination | 0.020 | 0.015 | 0.012 | |
| PBS/RPBS | Total | 0.021 | 0.016 | 0.014 | |
| SURVEY | Plain | 0.001 | 0.001 | 0.001 | |
| SURVEY | Combination | 0.002 | 0.001 | 0.001 | |
| SURVEY | Total | 0.003 | 0.002 | 0.002 | |
| DISODIUM PAMIDRONATE | |||||
| M05BA03 | PBS/RPBS | Plain | 0.001 | 0.001 | 0.001 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| IBANDRONIC ACID | |||||
| M05BA06 | PBS/RPBS | Plain | 0.000 | 0.114 | 0.186 |
| SURVEY | Plain | 0.000 | 0.000 | 0.001 | |
| RISEDRONIC ACID | |||||
| M05BA07 | PBS/RPBS | Plain | 1.698 | 1.596 | 2.145 |
| PBS/RPBS | Combination | 2.763 | 2.991 | 2.694 | |
| PBS/RPBS | Total | 4.461 | 4.587 | 4.839 | |
| SURVEY | Plain | 0.066 | 0.054 | 0.067 | |
| SURVEY | Combination | 0.084 | 0.079 | 0.051 | |
| SURVEY | Total | 0.150 | 0.133 | 0.118 | |
| TILUDRONIC ACID | |||||
| M05BA05 | PBS/RPBS | Plain | 0.002 | 0.002 | 0.002 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| ZOLEDRONIC ACID | |||||
| M05BA08 | PBS/RPBS | Plain | 0.003 | 0.003 | 0.003 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| BISPHOSPHONATES, COMBINATIONS | |||||
| ALENDRONATE SODIUM with COLECALCIFEROL and CALCIUM CARBONATE | |||||
| M05BB05 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.161 |
| SURVEY | Plain | 0.000 | 0.000 | 0.002 | |
| OTHER DRUGS AFFECTING BONE STRUCTURE | |||||
M05 - DRUGS FOR TREATMENT OF BONE DISEASES
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| MUSCULO-SKELETAL SYSTEM DRUGS FOR TREATMENT OF BONE DISEASES DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION DENOSUMAB |
|||||
| M05BX04 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.003 |
| SURVEY | Plain | 0.000 | 0.000 | 0.001 | |
| STRONTIUM RANELATE | |||||
| M05BX03 | PBS/RPBS | Plain | 0.548 | 0.810 | 0.988 |
| SURVEY | Plain | 0.022 | 0.034 | 0.037 | |
M09 - OTHER DRUGS FOR DISORD. OF MUSCULO-SKELETAL SYST.
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| MUSCULO-SKELETAL SYSTEM OTHER DRUGS FOR DISORD. OF MUSCULO-SKELETAL SYST. OTHER DRUGS FOR DISORD. OF MUSCULO-SKELETAL SYST. OTHER DRUGS FOR DISORD. OF MUSCULO-SKELETAL SYST. |
|||||
| HYALURONIC ACID | |||||
| M09AX01 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
N02 - ANALGESICS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| NERVOUS SYSTEM ANALGESICS OPIOIDS NATURAL OPIUM ALKALOIDS |
|||||
| HYDROMORPHONE | |||||
| N02AA03 | PBS/RPBS | Plain | 0.102 | 0.108 | 0.174 |
| SURVEY | Plain | 0.004 | 0.003 | 0.005 | |
| MORPHINE | |||||
| N02AA01 | PBS/RPBS | Plain | 1.541 | 1.459 | 1.385 |
| SURVEY | Plain | 0.096 | 0.086 | 0.077 | |
| OXYCODONE | |||||
| N02AA05 | PBS/RPBS | Plain | 2.030 | 2.229 | 2.451 |
| SURVEY | Plain | 0.188 | 0.213 | 0.221 | |
| PHENYLPIPERIDINE DERIVATIVES | |||||
| FENTANYL | |||||
| N02AB03 | PBS/RPBS | Plain | 0.674 | 0.882 | 1.067 |
| SURVEY | Plain | 0.007 | 0.007 | 0.009 | |
| PETHIDINE HYDROCHLORIDE | |||||
| N02AB02 | SURVEY | Plain | 0.005 | 0.003 | 0.004 |
| DIPHENYLPROPYLAMINE DERIVATIVES | |||||
| DEXTROPROPOXYPHENE NAPSYLATE | |||||
| N02AC04 | PBS/RPBS | Plain | 0.021 | 0.019 | 0.017 |
| SURVEY | Plain | 0.045 | 0.038 | 0.042 | |
| SURVEY | Combination | 0.223 | 0.204 | 0.191 | |
| SURVEY | Total | 0.268 | 0.242 | 0.233 | |
| ORIPAVINE DERIVATIVES | |||||
| BUPRENORPHINE | |||||
| N02AE01 | PBS/RPBS | Plain | 0.320 | 0.409 | 0.496 |
| SURVEY | Plain | 0.007 | 0.011 | 0.009 | |
| OTHER OPIOIDS | |||||
| TRAMADOL | |||||
| N02AX02 | PBS/RPBS | Plain | 2.666 | 2.709 | 2.799 |
| SURVEY | Plain | 0.552 | 0.590 | 0.614 | |
| OTHER ANALGESICS AND ANTIPYRETICS | |||||
| SALICYLIC ACID DERIVATIVES | |||||
| ASPIRIN | |||||
| N02BA01 | PBS/RPBS | Plain | 0.188 | 0.145 | 0.114 |
| PBS/RPBS | Combination | 0.000 | 0.000 | 0.000 | |
| PBS/RPBS | Total | 0.188 | 0.145 | 0.114 | |
| SURVEY | Plain | 0.011 | 0.008 | 0.006 | |
| SURVEY | Combination | 0.004 | 0.003 | 0.003 | |
| SURVEY | Total | 0.015 | 0.011 | 0.009 | |
| ANILIDES | |||||
| PARACETAMOL | |||||
| N02BE01 | PBS/RPBS | Plain | 17.827 | 20.060 | 22.851 |
N02 - ANALGESICS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| NERVOUS SYSTEM ANALGESICS OTHER ANALGESICS AND ANTIPYRETICS |
|||||
| PBS/RPBS | Combination | 3.019 | 2.931 | 2.953 | |
| PBS/RPBS | Total | 20.846 | 22.991 | 25.804 | |
| SURVEY | Plain | 0.811 | 1.002 | 1.139 | |
| SURVEY | Combination | 1.338 | 1.366 | 1.222 | |
| SURVEY | Total | 2.149 | 2.368 | 2.361 | |
| PARACETAMOL, COMBINATION EXCL. PSYCHOLEPTICS | |||||
| N02BE51 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| ANTIMIGRAINE PREPARATIONS | |||||
| ERGOT ALKALOIDS | |||||
| DIHYDROERGOTAMINE | |||||
| N02CA01 | PBS/RPBS | Plain | 0.001 | 0.001 | 0.001 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| METHYSERGIDE | |||||
| N02CA04 | PBS/RPBS | Plain | 0.026 | 0.024 | 0.023 |
| SURVEY | Plain | 0.001 | 0.001 | 0.001 | |
| SELECTIVE 5HT RECEPTOR AGONISTS | |||||
| ELETRIPTAN | |||||
| N02CC06 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| NARATRIPTAN | |||||
| N02CC02 | PBS/RPBS | Plain | 0.020 | 0.019 | 0.020 |
| SURVEY | Plain | 0.036 | 0.026 | 0.026 | |
| RIZATRIPTAN | |||||
| N02CC04 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.008 |
| SURVEY | Plain | 0.000 | 0.000 | 0.010 | |
| SUMATRIPTAN | |||||
| N02CC01 | PBS/RPBS | Plain | 0.090 | 0.095 | 0.108 |
| SURVEY | Plain | 0.159 | 0.101 | 0.120 | |
| ZOLMITRIPTAN | |||||
| N02CC03 | PBS/RPBS | Plain | 0.033 | 0.031 | 0.032 |
| SURVEY | Plain | 0.051 | 0.039 | 0.038 | |
| OTHER ANTIMIGRAINE PREPARATIONS | |||||
| PIZOTIFEN MALATE | |||||
| N02CX01 | PBS/RPBS | Plain | 0.388 | 0.379 | 0.382 |
| SURVEY | Plain | 0.248 | 0.192 | 0.187 | |
N03 - ANTIEPILEPTICS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| NERVOUS SYSTEM ANTIEPILEPTICS ANTIEPILEPTICS BARBITURATES AND DERIVATIVES |
|||||
| PHENOBARBITONE | |||||
| N03AA02 | PBS/RPBS | Plain | 0.099 | 0.091 | 0.086 |
| SURVEY | Plain | 0.026 | 0.023 | 0.023 | |
| PRIMIDONE | |||||
| N03AA03 | PBS/RPBS | Plain | 0.085 | 0.079 | 0.077 |
| SURVEY | Plain | 0.000 | 0.000 | 0.001 | |
| HYDANTOIN DERIVATIVES | |||||
| PHENYTOIN | |||||
| N03AB02 | PBS/RPBS | Plain | 1.118 | 1.045 | 1.009 |
| SURVEY | Plain | 0.361 | 0.306 | 0.265 | |
| SUCCINIMIDE DERIVATIVES | |||||
| ETHOSUXIMIDE | |||||
| N03AD01 | PBS/RPBS | Plain | 0.017 | 0.018 | 0.020 |
| SURVEY | Plain | 0.001 | 0.001 | 0.000 | |
| BENZODIAZEPINE DERIVATIVES | |||||
| CLONAZEPAM | |||||
| N03AE01 | PBS/RPBS | Plain | 0.150 | 0.132 | 0.128 |
| SURVEY | Plain | 0.214 | 0.221 | 0.226 | |
| CARBOXAMIDE DERIVATIVES | |||||
| CARBAMAZEPINE | |||||
| N03AF01 | PBS/RPBS | Plain | 1.637 | 1.389 | 1.376 |
| SURVEY | Plain | 0.160 | 0.288 | 0.277 | |
| OXCARBAZEPINE | |||||
| N03AF02 | PBS/RPBS | Plain | 0.067 | 0.071 | 0.072 |
| SURVEY | Plain | 0.001 | 0.001 | 0.002 | |
| FATTY ACID DERIVATIVES | |||||
| SODIUM VALPROATE | |||||
| N03AG01 | PBS/RPBS | Plain | 3.728 | 3.707 | 3.520 |
| SURVEY | Plain | 0.055 | 0.071 | 0.251 | |
| TIAGABINE | |||||
| N03AG06 | PBS/RPBS | Plain | 0.010 | 0.008 | 0.008 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| VIGABATRIN | |||||
| N03AG04 | PBS/RPBS | Plain | 0.045 | 0.042 | 0.039 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| OTHER ANTIEPILEPTICS | |||||
| GABAPENTIN | |||||
| N03AX12 | PBS/RPBS | Plain | 0.293 | 0.288 | 0.286 |
| SURVEY | Plain | 0.161 | 0.178 | 0.183 | |
| LACOSAMIDE | |||||
| N03AX18 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.014 |
N03 - ANTIEPILEPTICS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| NERVOUS SYSTEM ANTIEPILEPTICS ANTIEPILEPTICS |
|||||
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| LAMOTRIGINE | |||||
| N03AX09 | PBS/RPBS | Plain | 0.816 | 0.819 | 0.833 |
| SURVEY | Plain | 0.104 | 0.121 | 0.125 | |
| LEVETIRACETAM | |||||
| N03AX14 | PBS/RPBS | Plain | 0.578 | 0.686 | 0.793 |
| SURVEY | Plain | 0.005 | 0.008 | 0.009 | |
| PREGABALIN | |||||
| N03AX16 | PBS/RPBS | Plain | 0.034 | 0.060 | 0.075 |
| SURVEY | Plain | 0.306 | 0.403 | 0.489 | |
| SULTHIAME | |||||
| N03AX03 | PBS/RPBS | Plain | 0.024 | 0.024 | 0.023 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| TOPIRAMATE | |||||
| N03AX11 | PBS/RPBS | Plain | 0.317 | 0.350 | 0.378 |
| SURVEY | Plain | 0.020 | 0.023 | 0.023 | |
N04 - ANTI-PARKINSON DRUGS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| NERVOUS SYSTEM ANTI-PARKINSON DRUGS ANTICHOLINERGIC AGENTS TERTIARY AMINES WITH CARBON CHAIN |
|||||
| BENZHEXOL HYDROCHLORIDE | |||||
| N04AA01 | PBS/RPBS | Plain | 0.115 | 0.109 | 0.100 |
| SURVEY | Plain | 0.014 | 0.013 | 0.012 | |
| BIPERIDEN HYDROCHLORIDE | |||||
| N04AA02 | PBS/RPBS | Plain | 0.062 | 0.056 | 0.054 |
| SURVEY | Plain | 0.005 | 0.006 | 0.006 | |
| ETHERS OF TROPINE OR TROPINE DERIVATIVES | |||||
| BENZTROPINE MESYLATE | |||||
| N04AC01 | PBS/RPBS | Plain | 0.436 | 0.422 | 0.411 |
| SURVEY | Plain | 0.046 | 0.036 | 0.031 | |
| DOPAMINERGIC AGENTS | |||||
| DOPA AND DOPA DERIVATIVES | |||||
| LEVODOPA with BENSERAZIDE | |||||
| N04BA02 | PBS/RPBS | Plain | 0.567 | 0.564 | 0.598 |
| SURVEY | Plain | 0.004 | 0.003 | 0.004 | |
| LEVODOPA with CARBIDOPA | |||||
| N04BA02 | PBS/RPBS | Plain | 0.860 | 0.840 | 0.776 |
| SURVEY | Plain | 0.005 | 0.004 | 0.003 | |
| LEVODOPA with CARBIDOPA and ENTACAPONE | |||||
| N04BA03 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.007 |
| LEVODOPA,DECARBOXYLASE INHIBITOR and COMT INHIBITOR | |||||
| N04BA03 | PBS/RPBS | Plain | 0.081 | 0.111 | 0.152 |
| SURVEY | Plain | 0.000 | 0.000 | 0.002 | |
| ADAMANTANE DERIVATIVES | |||||
| AMANTADINE HYDROCHLORIDE | |||||
| N04BB01 | PBS/RPBS | Plain | 0.098 | 0.094 | 0.093 |
| SURVEY | Plain | 0.001 | 0.001 | 0.001 | |
| DOPAMINE AGONISTS | |||||
| APOMORPHINE | |||||
| N04BC07 | PBS/RPBS | Plain | 0.007 | 0.010 | 0.011 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| BROMOCRIPTINE MESYLATE | |||||
| N04BC01 | PBS/RPBS | Plain | 0.013 | 0.010 | 0.008 |
| SURVEY | Plain | 0.001 | 0.002 | 0.001 | |
| CABERGOLINE | |||||
| N04BC06 | PBS/RPBS | Plain | 0.202 | 0.095 | 0.067 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| PERGOLIDE | |||||
| N04BC02 | PBS/RPBS | Plain | 0.012 | 0.008 | 0.006 |
| SURVEY | Plain | 0.001 | 0.001 | 0.000 | |
| PRAMIPEXOLE | |||||
N04 - ANTI-PARKINSON DRUGS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| NERVOUS SYSTEM ANTI-PARKINSON DRUGS DOPAMINERGIC AGENTS |
|||||
| N04BC05 | PBS/RPBS | Plain | 0.045 | 0.172 | 0.251 |
| SURVEY | Plain | 0.000 | 0.000 | 0.002 | |
| ROPINIROLE | |||||
| N04BC04 | SURVEY | Plain | 0.008 | 0.005 | 0.004 |
| MONOAMINE OXIDASE TYPE B INHIBITORS | |||||
| SELEGILINE HYDROCHLORIDE | |||||
| N04BD01 | PBS/RPBS | Plain | 0.078 | 0.072 | 0.070 |
| SURVEY | Plain | 0.001 | 0.002 | 0.003 | |
| OTHER DOPAMINERGIC AGENTS | |||||
| ENTACAPONE | |||||
| N04BX02 | PBS/RPBS | Plain | 0.089 | 0.079 | 0.071 |
| SURVEY | Plain | 0.001 | 0.001 | 0.001 | |
N05 - PSYCHOLEPTICS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| NERVOUS SYSTEM PSYCHOLEPTICS ANTIPSYCHOTICS PHENOTHIAZINE WITH DIMETHYLAMINOPROPYL GROUP |
|||||
| CHLORPROMAZINE HYDROCHLORIDE | |||||
| N05AA01 | PBS/RPBS | Plain | 0.154 | 0.146 | 0.137 |
| SURVEY | Plain | 0.019 | 0.016 | 0.015 | |
| PHENOTHIAZINE WITH PIPERAZINE STRUCTURE | |||||
| FLUPHENAZINE DECANOATE | |||||
| N05AB02 | PBS/RPBS | Plain | 0.223 | 0.204 | 0.190 |
| SURVEY | Plain | 0.007 | 0.006 | 0.004 | |
| PROCHLORPERAZINE | |||||
| N05AB04 | PBS/RPBS | Plain | 0.120 | 0.116 | 0.114 |
| SURVEY | Plain | 0.047 | 0.044 | 0.043 | |
| TRIFLUOPERAZINE HYDROCHLORIDE | |||||
| N05AB06 | PBS/RPBS | Plain | 0.064 | 0.058 | 0.054 |
| SURVEY | Plain | 0.012 | 0.010 | 0.007 | |
| PHENOTHIAZINE WITH PIPERIDINE STRUCTURE | |||||
| PERICYAZINE | |||||
| N05AC01 | PBS/RPBS | Plain | 0.058 | 0.054 | 0.051 |
| SURVEY | Plain | 0.008 | 0.006 | 0.008 | |
| THIORIDAZINE HYDROCHLORIDE | |||||
| N05AC02 | SURVEY | Plain | 0.002 | 0.000 | 0.000 |
| BUTYROPHENONE DERIVATIVES | |||||
| HALOPERIDOL | |||||
| N05AD01 | PBS/RPBS | Plain | 0.241 | 0.224 | 0.214 |
| SURVEY | Plain | 0.014 | 0.016 | 0.016 | |
| INDOLE DERIVATIVES | |||||
| ZIPRASIDONE | |||||
| N05AE04 | PBS/RPBS | Plain | 0.121 | 0.155 | 0.179 |
| SURVEY | Plain | 0.038 | 0.048 | 0.051 | |
| THIOXANTHENE DERIVATIVES | |||||
| FLUPENTHIXOL | |||||
| N05AF01 | PBS/RPBS | Plain | 0.115 | 0.116 | 0.118 |
| SURVEY | Plain | 0.002 | 0.003 | 0.002 | |
| ZUCLOPENTHIXOL | |||||
| N05AF05 | PBS/RPBS | Plain | 0.200 | 0.208 | 0.220 |
| SURVEY | Plain | 0.015 | 0.012 | 0.010 | |
| DIPHENYLBUTYLPIPERIDINE DERIVATIVES | |||||
| PIMOZIDE | |||||
| N05AG02 | SURVEY | Plain | 0.000 | 0.000 | 0.001 |
| DIAZEPINES, OXAZEPINES, THIAZEPINES AND OXEPINES | |||||
| CLOZAPINE | |||||
| N05AH02 | PBS/RPBS | Plain | 0.053 | 0.053 | 0.056 |
| SURVEY | Plain | 0.210 | 0.186 | 0.196 | |
N05 - PSYCHOLEPTICS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| NERVOUS SYSTEM PSYCHOLEPTICS ANTIPSYCHOTICS OLANZAPINE |
|||||
| N05AH03 | PBS/RPBS | Plain | 3.038 | 3.019 | 3.012 |
| SURVEY | Plain | 0.069 | 0.065 | 0.043 | |
| QUETIAPINE | |||||
| N05AH04 | PBS/RPBS | Plain | 1.364 | 1.646 | 1.952 |
| SURVEY | Plain | 0.117 | 0.113 | 0.098 | |
| BENZAMIDES | |||||
| AMISULPRIDE | |||||
| N05AL05 | PBS/RPBS | Plain | 0.438 | 0.416 | 0.403 |
| SURVEY | Plain | 0.006 | 0.007 | 0.004 | |
| LITHIUM | |||||
| LITHIUM CARBONATE | |||||
| N05AN01 | PBS/RPBS | Plain | 0.896 | 0.906 | 0.936 |
| SURVEY | Plain | 0.268 | 0.247 | 0.236 | |
| OTHER ANTIPSYCHOTICS | |||||
| ARIPIPRAZOLE | |||||
| N05AX12 | PBS/RPBS | Plain | 0.492 | 0.522 | 0.558 |
| SURVEY | Plain | 0.009 | 0.012 | 0.009 | |
| PALIPERIDONE | |||||
| N05AX13 | PBS/RPBS | Plain | 0.029 | 0.079 | 0.098 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| RISPERIDONE | |||||
| N05AX08 | PBS/RPBS | Plain | 1.450 | 1.481 | 1.492 |
| SURVEY | Plain | 0.020 | 0.018 | 0.021 | |
| ANXIOLYTICS | |||||
| BENZODIAZEPINE DERIVATIVES | |||||
| ALPRAZOLAM | |||||
| N05BA12 | PBS/RPBS | Plain | 3.850 | 3.890 | 3.833 |
| SURVEY | Plain | 2.219 | 2.307 | 2.298 | |
| BROMAZEPAM | |||||
| N05BA08 | PBS/RPBS | Plain | 0.006 | 0.005 | 0.004 |
| SURVEY | Plain | 0.149 | 0.134 | 0.120 | |
| CLOBAZAM | |||||
| N05BA09 | SURVEY | Plain | 0.069 | 0.069 | 0.072 |
| DIAZEPAM | |||||
| N05BA01 | PBS/RPBS | Plain | 4.918 | 4.816 | 4.682 |
| SURVEY | Plain | 1.589 | 1.516 | 1.548 | |
| LORAZEPAM | |||||
| N05BA06 | SURVEY | Plain | 0.396 | 0.404 | 0.409 |
| OXAZEPAM | |||||
| N05BA04 | PBS/RPBS | Plain | 2.015 | 1.878 | 1.752 |
| SURVEY | Plain | 0.431 | 0.409 | 0.387 | |
N05 - PSYCHOLEPTICS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| NERVOUS SYSTEM PSYCHOLEPTICS ANXIOLYTICS AZASPIRODECANEDIONE DERIVATIVES |
|||||
| BUSPIRONE HYDROCHLORIDE | |||||
| N05BE01 | PBS/RPBS | Plain | 0.003 | 0.002 | 0.002 |
| SURVEY | Plain | 0.006 | 0.008 | 0.007 | |
| HYPNOTICS AND SEDATIVES | |||||
| ALDEHYDES AND DERIVATIVES | |||||
| CHLORAL HYDRATE | |||||
| N05CC01 | SURVEY | Plain | 0.000 | 0.000 | 0.001 |
| BENZODIAZEPINE DERIVATIVES | |||||
| FLUNITRAZEPAM | |||||
| N05CD03 | PBS/RPBS | Plain | 0.041 | 0.036 | 0.031 |
| SURVEY | Plain | 0.349 | 0.289 | 0.264 | |
| MIDAZOLAM | |||||
| N05CD08 | SURVEY | Plain | 0.006 | 0.007 | 0.008 |
| NITRAZEPAM | |||||
| N05CD02 | PBS/RPBS | Plain | 1.700 | 1.549 | 1.419 |
| SURVEY | Plain | 0.302 | 0.286 | 0.283 | |
| TEMAZEPAM | |||||
| N05CD07 | PBS/RPBS | Plain | 3.464 | 3.264 | 3.075 |
| SURVEY | Plain | 1.082 | 1.042 | 0.974 | |
| TRIAZOLAM | |||||
| N05CD05 | SURVEY | Plain | 0.021 | 0.017 | 0.021 |
| BENZODIAZEPINE RELATED DRUGS | |||||
| ZOLPIDEM | |||||
| N05CF02 | SURVEY | Plain | 0.910 | 0.804 | 0.734 |
| ZOPICLONE | |||||
| N05CF01 | PBS/RPBS | Plain | 0.105 | 0.100 | 0.097 |
| SURVEY | Plain | 0.339 | 0.379 | 0.407 | |
N06 - PSYCHOANALEPTICS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| NERVOUS SYSTEM PSYCHOANALEPTICS ANTIDEPRESSANTS NON SELECTIVE MONOAMINE REUPTAKE INHIBITORS |
|||||
| AMITRIPTYLINE HYDROCHLORIDE | |||||
| N06AA09 | PBS/RPBS | Plain | 2.796 | 2.849 | 2.949 |
| SURVEY | Plain | 0.891 | 0.882 | 0.863 | |
| CLOMIPRAMINE HYDROCHLORIDE | |||||
| N06AA04 | PBS/RPBS | Plain | 0.205 | 0.192 | 0.190 |
| SURVEY | Plain | 0.050 | 0.054 | 0.053 | |
| DOTHIEPIN HYDROCHLORIDE | |||||
| N06AA16 | PBS/RPBS | Plain | 0.853 | 0.793 | 0.753 |
| SURVEY | Plain | 0.345 | 0.305 | 0.278 | |
| DOXEPIN HYDROCHLORIDE | |||||
| N06AA12 | PBS/RPBS | Plain | 0.738 | 0.677 | 0.633 |
| SURVEY | Plain | 0.142 | 0.127 | 0.109 | |
| IMIPRAMINE HYDROCHLORIDE | |||||
| N06AA02 | PBS/RPBS | Plain | 0.247 | 0.223 | 0.206 |
| SURVEY | Plain | 0.067 | 0.056 | 0.049 | |
| NORTRIPTYLINE HYDROCHLORIDE | |||||
| N06AA10 | PBS/RPBS | Plain | 0.177 | 0.183 | 0.194 |
| SURVEY | Plain | 0.077 | 0.080 | 0.081 | |
| TRIMIPRAMINE MALEATE | |||||
| N06AA06 | SURVEY | Plain | 0.023 | 0.016 | 0.015 |
| SELECTIVE SEROTONIN REUPTAKE INHIBITORS | |||||
| CITALOPRAM | |||||
| N06AB04 | PBS/RPBS | Plain | 5.945 | 5.823 | 5.717 |
| SURVEY | Plain | 2.223 | 1.991 | 1.746 | |
| ESCITALOPRAM | |||||
| N06AB10 | PBS/RPBS | Plain | 5.136 | 6.087 | 7.040 |
| SURVEY | Plain | 4.239 | 4.566 | 4.835 | |
| FLUOXETINE HYDROCHLORIDE | |||||
| N06AB03 | PBS/RPBS | Plain | 4.311 | 4.316 | 4.380 |
| SURVEY | Plain | 2.208 | 2.089 | 2.047 | |
| FLUVOXAMINE | |||||
| N06AB08 | PBS/RPBS | Plain | 1.709 | 1.391 | 1.338 |
| SURVEY | Plain | 0.347 | 0.590 | 0.529 | |
| PAROXETINE | |||||
| N06AB05 | PBS/RPBS | Plain | 3.869 | 3.657 | 3.530 |
| SURVEY | Plain | 1.872 | 1.626 | 1.481 | |
| SERTRALINE | |||||
| N06AB06 | PBS/RPBS | Plain | 12.574 | 12.346 | 12.384 |
| SURVEY | Plain | 7.202 | 6.622 | 6.210 | |
| MONOAMINE OXIDASE INHIBITORS, NON-SELECTIVE | |||||
| PHENELZINE SULPHATE | |||||
N06 - PSYCHOANALEPTICS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| NERVOUS SYSTEM PSYCHOANALEPTICS ANTIDEPRESSANTS |
|||||
| N06AF03 | PBS/RPBS | Plain | 0.029 | 0.029 | 0.029 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| TRANYLCYPROMINE SULPHATE | |||||
| N06AF04 | PBS/RPBS | Plain | 0.238 | 0.243 | 0.245 |
| SURVEY | Plain | 0.037 | 0.003 | 0.004 | |
| MONOAMINE OXIDASE TYPE A INHIBITORS | |||||
| MOCLOBEMIDE | |||||
| N06AG02 | PBS/RPBS | Plain | 1.081 | 0.818 | 0.751 |
| SURVEY | Plain | 0.177 | 0.293 | 0.239 | |
| OTHER ANTIDEPRESSANTS | |||||
| AGOMELATINE | |||||
| N06AX22 | SURVEY | Plain | 0.000 | 0.000 | 0.010 |
| BUPROPION | |||||
| N06AX12 | PBS/RPBS | Plain | 0.128 | 0.064 | 0.062 |
| SURVEY | Plain | 0.022 | 0.014 | 0.015 | |
| DULOXETINE | |||||
| N06AX21 | PBS/RPBS | Plain | 0.308 | 1.500 | 2.523 |
| SURVEY | Plain | 0.006 | 0.026 | 0.036 | |
| MIANSERIN HYDROCHLORIDE | |||||
| N06AX03 | PBS/RPBS | Plain | 0.148 | 0.134 | 0.128 |
| SURVEY | Plain | 0.024 | 0.021 | 0.018 | |
| MIRTAZAPINE | |||||
| N06AX11 | PBS/RPBS | Plain | 4.848 | 4.698 | 5.057 |
| SURVEY | Plain | 0.404 | 0.813 | 0.756 | |
| REBOXETINE | |||||
| N06AX18 | PBS/RPBS | Plain | 0.369 | 0.303 | 0.266 |
| SURVEY | Plain | 0.005 | 0.003 | 0.001 | |
| VENLAFAXINE | |||||
| N06AX16 | PBS/RPBS | Plain | 13.446 | 13.173 | 12.452 |
| SURVEY | Plain | 0.222 | 0.197 | 0.154 | |
| PSYCHOSTIMULANTS AND NOOTROPICS | |||||
| CENTRALLY ACTING SYMPATHOMIMETICS | |||||
| ATOMOXETINE | |||||
| N06BA09 | PBS/RPBS | Plain | 0.069 | 0.085 | 0.096 |
| SURVEY | Plain | 0.008 | 0.006 | 0.007 | |
| DEXAMPHETAMINE SULPHATE | |||||
| N06BA02 | PBS/RPBS | Plain | 1.029 | 1.056 | 1.075 |
| SURVEY | Plain | 0.719 | 0.724 | 0.727 | |
| METHYLPHENIDATE | |||||
| N06BA04 | PBS/RPBS | Plain | 1.399 | 1.563 | 1.714 |
| SURVEY | Plain | 0.303 | 0.289 | 0.269 | |
| MODAFINIL | |||||
N06 - PSYCHOANALEPTICS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| NERVOUS SYSTEM PSYCHOANALEPTICS PSYCHOSTIMULANTS AND NOOTROPICS |
|||||
| N06BA07 | PBS/RPBS | Plain | 0.009 | 0.013 | 0.021 |
| SURVEY | Plain | 0.015 | 0.014 | 0.015 | |
| ANTI-DEMENTIA DRUGS | |||||
| ANTICHOLINESTERASES | |||||
| DONEPEZIL | |||||
| N06DA02 | PBS/RPBS | Plain | 1.017 | 0.997 | 1.001 |
| SURVEY | Plain | 0.016 | 0.014 | 0.017 | |
| GALANTAMINE | |||||
| N06DA04 | PBS/RPBS | Plain | 0.408 | 0.392 | 0.374 |
| SURVEY | Plain | 0.006 | 0.006 | 0.007 | |
| RIVASTIGMINE | |||||
| N06DA03 | PBS/RPBS | Plain | 0.048 | 0.080 | 0.106 |
| SURVEY | Plain | 0.001 | 0.001 | 0.002 | |
| OTHER ANTI-DEMENTIA DRUGS | |||||
| MEMANTINE HYDROCHLORIDE | |||||
| N06DX01 | PBS/RPBS | Plain | 0.011 | 0.041 | 0.058 |
| SURVEY | Plain | 0.035 | 0.035 | 0.032 | |
N07 - OTHER NERVOUS SYSTEM DRUGS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| NERVOUS SYSTEM OTHER NERVOUS SYSTEM DRUGS PARASYMPATHOMIMETICS ANTICHOLINESTERASES |
|||||
| PYRIDOSTIGMINE BROMIDE | |||||
| N07AA02 | PBS/RPBS | Plain | 0.110 | 0.111 | 0.114 |
| SURVEY | Plain | 0.001 | 0.002 | 0.002 | |
| CHOLINE ESTERS | |||||
| BETHANECHOL CHLORIDE | |||||
| N07AB02 | PBS/RPBS | Plain | 0.019 | 0.019 | 0.017 |
| SURVEY | Plain | 0.005 | 0.005 | 0.005 | |
| DRUGS USED IN ADDICTIVE DISORDERS | |||||
| DRUGS USED IN NICOTINE DEPENDENCE | |||||
| NICOTINE | |||||
| N07BA01 | PBS/RPBS | Plain | 0.005 | 0.008 | 0.010 |
| SURVEY | Plain | 0.001 | 0.001 | 0.004 | |
| VARENICLINE | |||||
| N07BA03 | PBS/RPBS | Plain | 1.593 | 2.052 | 2.130 |
| SURVEY | Plain | 0.042 | 0.087 | 0.100 | |
| DRUGS USED IN ALCOHOL DEPENDENCE | |||||
| ACAMPROSATE | |||||
| N07BB03 | PBS/RPBS | Plain | 0.112 | 0.113 | 0.113 |
| SURVEY | Plain | 0.002 | 0.001 | 0.001 | |
| NALTREXONE | |||||
| N07BB04 | PBS/RPBS | Plain | 0.085 | 0.087 | 0.090 |
| SURVEY | Plain | 0.003 | 0.003 | 0.002 | |
| DRUGS USED IN OPIOID DEPENDENCE | |||||
| BUPRENORPHINE | |||||
| N07BC01 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| METHADONE HYDROCHLORIDE | |||||
| N07BC02 | PBS/RPBS | Plain | 0.370 | 0.368 | 0.363 |
| SURVEY | Plain | 0.163 | 0.165 | 0.253 | |
| ANTIVERTIGO PREPARATIONS | |||||
| ANTIVERTIGO PREPARATIONS | |||||
| BETAHISTINE | |||||
| N07CA01 | SURVEY | Plain | 0.366 | 0.367 | 0.390 |
| OTHER NERVOUS SYSTEM DRUGS | |||||
| OTHER NERVOUS SYSTEM DRUGS | |||||
| RILUZOLE | |||||
| N07XX02 | PBS/RPBS | Plain | 0.026 | 0.026 | 0.026 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| TETRABENAZINE | |||||
| N07XX06 | PBS/RPBS | Plain | 0.021 | 0.022 | 0.022 |
| SURVEY | Plain | 0.000 | 0.000 | 0.001 | |
P01 - ANTIPROTOZOALS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS ANTIPROTOZOALS AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES NITROIMIDAZOLE DERIVATIVES |
|||||
| METRONIDAZOLE | |||||
| P01AB01 | PBS/RPBS | Plain | 0.131 | 0.134 | 0.139 |
| SURVEY | Plain | 0.177 | 0.172 | 0.170 | |
| TINIDAZOLE | |||||
| P01AB02 | PBS/RPBS | Plain | 0.006 | 0.006 | 0.006 |
| SURVEY | Plain | 0.015 | 0.014 | 0.013 | |
| OTHER AGENTS AGAINST AMOEBIASIS | |||||
| ATOVAQUONE | |||||
| P01AX06 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| ANTIMALARIALS | |||||
| QUINOLINE DERIVATIVES | |||||
| CHLOROQUINE | |||||
| P01BA01 | SURVEY | Plain | 0.007 | 0.000 | 0.000 |
| HYDROXYCHLOROQUINE SULPHATE | |||||
| P01BA02 | PBS/RPBS | Plain | 0.609 | 0.641 | 0.693 |
| SURVEY | Plain | 0.004 | 0.006 | 0.007 | |
| PRIMAQUINE PHOSPHATE | |||||
| P01BA03 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| BIGUANIDES | |||||
| PROGUANIL | |||||
| P01BB01 | SURVEY | Plain | 0.000 | 0.001 | 0.000 |
| METHANOLQUINOLINES | |||||
| MEFLOQUINE | |||||
| P01BC02 | SURVEY | Plain | 0.004 | 0.003 | 0.004 |
| QUININE | |||||
| P01BC01 | PBS/RPBS | Plain | 0.007 | 0.007 | 0.005 |
| SURVEY | Plain | 0.205 | 0.174 | 0.119 | |
| DIAMINOPYRIMIDINES | |||||
| PYRIMETHAMINE with SULFADOXINE | |||||
| P01BD51 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
P02 - ANTHELMINTICS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS ANTHELMINTICS ANTITREMATODALS QUINOLINE DERIVATIVES |
|||||
| PRAZIQUANTEL | |||||
| P02BA01 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| ANTINEMATODAL AGENTS | |||||
| BENZIMIDAZOLE DERIVATIVES | |||||
| ALBENDAZOLE | |||||
| P02CA03 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| SURVEY | Plain | 0.000 | 0.000 | 0.001 | |
| MEBENDAZOLE | |||||
| P02CA01 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| TETRAHYDROPYRIMIDINE DERIVATIVES | |||||
| PYRANTEL EMBONATE | |||||
| P02CC01 | PBS/RPBS | Plain | 0.001 | 0.001 | 0.000 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| AVERMECTINES | |||||
| IVERMECTIN | |||||
| P02CF01 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
R01 - NASAL PREPARATIONS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| RESPIRATORY SYSTEM NASAL PREPARATIONS DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE SYMPATHOMIMETICS, PLAIN |
|||||
| OXYMETAZOLINE | |||||
| R01AA05 | PBS/RPBS | Plain | 0.004 | 0.004 | 0.002 |
| SURVEY | Plain | 0.001 | 0.004 | 0.003 | |
| XYLOMETAZOLINE | |||||
| R01AA07 | SURVEY | Plain | 0.001 | 0.001 | 0.001 |
| ANTIALLERGIC AGENTS,EXCL.CORTICOSTEROIDS | |||||
| LEVOCABASTINE | |||||
| R01AC02 | PBS/RPBS | Plain | 0.002 | 0.002 | 0.001 |
| SURVEY | Plain | 0.001 | 0.001 | 0.000 | |
| SODIUM CROMOGLYCATE | |||||
| R01AC01 | PBS/RPBS | Plain | 0.001 | 0.001 | 0.001 |
| SURVEY | Plain | 0.001 | 0.000 | 0.000 | |
| CORTICOSTEROIDS | |||||
| BECLOMETHASONE DIPROPIONATE | |||||
| R01AD01 | SURVEY | Plain | 0.012 | 0.008 | 0.010 |
| BUDESONIDE | |||||
| R01AD05 | PBS/RPBS | Plain | 0.094 | 0.089 | 0.082 |
| SURVEY | Plain | 1.236 | 1.108 | 0.935 | |
| FLUTICASONE | |||||
| R01AD08 | SURVEY | Plain | 0.004 | 0.007 | 0.019 |
| FLUTICASONE FUROATE | |||||
| R01AD12 | SURVEY | Plain | 0.006 | 0.195 | 0.383 |
| MOMETASONE FUROATE | |||||
| R01AD09 | SURVEY | Plain | 2.427 | 2.352 | 2.353 |
| OTHER NASAL PREPARATIONS | |||||
| IPRATROPIUM BROMIDE | |||||
| R01AX03 | PBS/RPBS | Plain | 0.046 | 0.043 | 0.039 |
| SURVEY | Plain | 0.017 | 0.014 | 0.015 | |
| NASAL DECONGESTANTS FOR SYSTEMIC USE | |||||
| SYMPATHOMIMETICS | |||||
| PSEUDOEPHEDRINE | |||||
| R01BA02 | PBS/RPBS | Plain | 0.001 | 0.000 | 0.000 |
| SURVEY | Plain | 0.008 | 0.007 | 0.009 | |
| SURVEY | Combination | 0.000 | 0.000 | 0.000 | |
| SURVEY | Total | 0.008 | 0.007 | 0.009 | |
R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| RESPIRATORY SYSTEM DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES ADRENERGICS, INHALANTS SELECTIVE BETA-2-ADRENOCEPTOR AGONISTS |
|||||
| EFORMOTEROL | |||||
| R03AC13 | PBS/RPBS | Plain | 0.332 | 0.296 | 0.264 |
| PBS/RPBS | Combination | 4.265 | 4.672 | 5.182 | |
| PBS/RPBS | Total | 4.597 | 4.968 | 5.446 | |
| SURVEY | Plain | 0.005 | 0.006 | 0.006 | |
| SURVEY | Combination | 0.019 | 0.019 | 0.019 | |
| SURVEY | Total | 0.024 | 0.025 | 0.025 | |
| SALBUTAMOL | |||||
| R03AC02 | PBS/RPBS | Plain | 16.106 | 15.651 | 15.920 |
| SURVEY | Plain | 5.058 | 4.826 | 4.688 | |
| SALMETEROL | |||||
| R03AC12 | PBS/RPBS | Plain | 0.182 | 0.149 | 0.138 |
| PBS/RPBS | Combination | 11.237 | 11.039 | 11.193 | |
| PBS/RPBS | Total | 11.419 | 11.188 | 11.331 | |
| SURVEY | Plain | 0.021 | 0.001 | 0.001 | |
| SURVEY | Combination | 0.031 | 0.026 | 0.028 | |
| SURVEY | Total | 0.052 | 0.027 | 0.029 | |
| TERBUTALINE SULPHATE | |||||
| R03AC03 | PBS/RPBS | Plain | 1.430 | 1.266 | 1.154 |
| SURVEY | Plain | 0.646 | 0.505 | 0.420 | |
| OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,INHALANTS | |||||
| GLUCOCORTICOIDS | |||||
| BECLOMETHASONE DIPROPIONATE | |||||
| R03BA01 | PBS/RPBS | Plain | 0.259 | 0.260 | 0.233 |
| SURVEY | Plain | 0.046 | 0.009 | 0.009 | |
| BUDESONIDE | |||||
| R03BA02 | PBS/RPBS | Plain | 1.892 | 1.613 | 1.434 |
| PBS/RPBS | Combination | 4.196 | 4.597 | 5.104 | |
| PBS/RPBS | Total | 6.088 | 6.210 | 6.538 | |
| SURVEY | Plain | 0.214 | 0.200 | 0.176 | |
| SURVEY | Combination | 0.019 | 0.018 | 0.019 | |
| SURVEY | Total | 0.233 | 0.218 | 0.195 | |
| CICLESONIDE | |||||
| R03BA08 | PBS/RPBS | Plain | 0.976 | 1.118 | 1.175 |
| SURVEY | Plain | 0.036 | 0.035 | 0.040 | |
| FLUTICASONE | |||||
| R03BA05 | PBS/RPBS | Plain | 1.216 | 1.122 | 1.098 |
| PBS/RPBS | Combination | 14.595 | 14.455 | 14.762 | |
| PBS/RPBS | Total | 15.811 | 15.577 | 15.860 | |
| SURVEY | Plain | 0.414 | 0.389 | 0.381 | |
| SURVEY | Combination | 0.037 | 0.030 | 0.032 | |
R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| RESPIRATORY SYSTEM DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,INHALANTS |
|||||
| SURVEY | Total | 0.451 | 0.419 | 0.413 | |
| ANTICHOLINERGICS | |||||
| IPRATROPIUM BROMIDE | |||||
| R03BB01 | PBS/RPBS | Plain | 4.113 | 3.664 | 3.351 |
| SURVEY | Plain | 0.034 | 0.032 | 0.030 | |
| TIOTROPIUM BROMIDE | |||||
| R03BB04 | PBS/RPBS | Plain | 5.775 | 5.975 | 6.313 |
| SURVEY | Plain | 0.007 | 0.006 | 0.007 | |
| ANTIALLERGIC AGENTS, EXCL. CORTICOSTEROIDS | |||||
| NEDOCROMIL | |||||
| R03BC03 | PBS/RPBS | Plain | 0.227 | 0.213 | 0.206 |
| SURVEY | Plain | 0.003 | 0.003 | 0.002 | |
| SODIUM CROMOGLYCATE | |||||
| R03BC01 | PBS/RPBS | Plain | 0.068 | 0.058 | 0.052 |
| SURVEY | Plain | 0.001 | 0.003 | 0.004 | |
| ADRENERGICS FOR SYSTEMIC USE | |||||
| SELECTIVE BETA-2-ADRENOCEPTOR AGONISTS | |||||
| SALBUTAMOL | |||||
| R03CC02 | PBS/RPBS | Plain | 0.047 | 0.036 | 0.033 |
| SURVEY | Plain | 0.009 | 0.013 | 0.012 | |
| TERBUTALINE SULPHATE | |||||
| R03CC03 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| SURVEY | Plain | 0.190 | 0.142 | 0.133 | |
| OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES | |||||
| XANTHINES | |||||
| CHOLINE THEOPHYLLINATE | |||||
| R03DA02 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| THEOPHYLLINE | |||||
| R03DA04 | PBS/RPBS | Plain | 0.429 | 0.383 | 0.356 |
| SURVEY | Plain | 0.098 | 0.081 | 0.065 | |
| LEUKOTRIENERECEPTOR ANTAGONISTS | |||||
| MONTELUKAST | |||||
| R03DC03 | PBS/RPBS | Plain | 0.267 | 0.289 | 0.325 |
| SURVEY | Plain | 0.161 | 0.157 | 0.160 | |
| ZAFIRLUKAST | |||||
| R03DC01 | SURVEY | Plain | 0.002 | 0.000 | 0.000 |
R05 - COUGH AND COLD PREPARATIONS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| RESPIRATORY SYSTEM COUGH AND COLD PREPARATIONS EXPECTORANTS,EXCL COMBINATIONS WITH ANTITUSSIVES MUCOLYTICS |
|||||
| ACETYLCYSTEINE | |||||
| R05CB01 | PBS/RPBS | Plain | 0.017 | 0.016 | 0.002 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| BROMHEXINE HYDROCHLORIDE | |||||
| R05CB02 | SURVEY | Plain | 0.015 | 0.013 | 0.014 |
| DORNASE ALFA (DESOXYRIBONUCLEASE) | |||||
| R05CB13 | PBS/RPBS | Plain | 0.000 | 0.000 | 0.000 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| COUGH SUPPRESSANTS, EXCL.COMBINATIONS WITH EXPECTORANTS | |||||
| OPIUM ALKALOIDS AND DERIVATIVES | |||||
| CODEINE | |||||
| R05DA04 | PBS/RPBS | Plain | 0.127 | 0.126 | 0.126 |
| PBS/RPBS | Combination | 5.399 | 5.245 | 5.289 | |
| PBS/RPBS | Total | 5.526 | 5.371 | 5.415 | |
| SURVEY | Plain | 0.040 | 0.035 | 0.034 | |
| SURVEY | Combination | 2.081 | 2.164 | 1.872 | |
| SURVEY | Total | 2.121 | 2.199 | 1.906 | |
| CODEINE with PSEUDOEPHEDRINE | |||||
| R05DA20 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| PHOLCODINE | |||||
| R05DA08 | PBS/RPBS | Plain | 0.001 | 0.001 | 0.001 |
| SURVEY | Plain | 0.001 | 0.001 | 0.001 | |
| PHOLCODINE with PSEUDOEPHEDRINE | |||||
| R05DA20 | SURVEY | Plain | 0.000 | 0.001 | 0.000 |
R06 - ANTIHISTAMINES FOR SYSTEMIC USE
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| RESPIRATORY SYSTEM ANTIHISTAMINES FOR SYSTEMIC USE ANTIHISTAMINES FOR SYSTEMIC USE AMINOALKYL ETHERS |
|||||
| DIMENHYDRINATE | |||||
| R06AA02 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| DIPHENHYDRAMINE | |||||
| R06AA02 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| SUBSTITUTED ALKYLAMINES | |||||
| BROMPHENIRAMINE COMBINATIONS | |||||
| R06AB51 | SURVEY | Plain | 0.005 | 0.003 | 0.000 |
| CHLORPHENIRAMINE | |||||
| R06AB04 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| SURVEY | Combination | 0.000 | 0.000 | 0.000 | |
| SURVEY | Total | 0.000 | 0.000 | 0.000 | |
| DEXCHLORPHENIRAMINE | |||||
| R06AB02 | SURVEY | Plain | 0.053 | 0.044 | 0.022 |
| PHENIRAMINE | |||||
| R06AB05 | SURVEY | Plain | 0.006 | 0.005 | 0.004 |
| PHENOTHIAZINE DERIVATIVES | |||||
| PROMETHAZINE | |||||
| R06AD02 | PBS/RPBS | Plain | 0.114 | 0.104 | 0.091 |
| SURVEY | Plain | 0.263 | 0.233 | 0.215 | |
| TRIMEPRAZINE | |||||
| R06AD01 | SURVEY | Plain | 0.006 | 0.004 | 0.003 |
| PIPERAZINE DERIVATIVES | |||||
| CETIRIZINE | |||||
| R06AE07 | PBS/RPBS | Plain | 0.054 | 0.051 | 0.048 |
| SURVEY | Plain | 0.022 | 0.019 | 0.020 | |
| OTHER ANTIHISTAMINES FOR SYSTEMIC USE | |||||
| CYPROHEPTADINE HYDROCHLORIDE | |||||
| R06AX02 | PBS/RPBS | Plain | 0.287 | 0.275 | 0.266 |
| SURVEY | Plain | 0.042 | 0.045 | 0.041 | |
| DESLORATADINE | |||||
| R06AX27 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| FEXOFENADINE | |||||
| R06AX26 | PBS/RPBS | Plain | 0.579 | 0.530 | 0.499 |
| SURVEY | Plain | 0.105 | 0.076 | 0.039 | |
| LORATADINE | |||||
| R06AX13 | PBS/RPBS | Plain | 0.138 | 0.127 | 0.119 |
| SURVEY | Plain | 0.028 | 0.024 | 0.029 | |
| LORATADINE with PSEUDOEPHEDRINE | |||||
| R06AX13 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
S01 - OPHTHALMOLOGICALS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| SENSORY ORGANS OPHTHALMOLOGICALS ANTIGLAUCOMA PREPARATIONS AND MIOTICS SYMPATHOMIMETICS IN GLAUCOMA THERAPY |
|||||
| APRACLONIDINE | |||||
| S01EA03 | PBS/RPBS | Plain | 0.028 | 0.030 | 0.032 |
| SURVEY | Plain | 0.000 | 0.001 | 0.001 | |
| BRIMONIDINE | |||||
| S01EA05 | PBS/RPBS | Plain | 0.580 | 0.584 | 0.578 |
| SURVEY | Plain | 0.067 | 0.066 | 0.065 | |
| DIPIVEFRINE | |||||
| S01EA02 | PBS/RPBS | Plain | 0.025 | 0.000 | 0.000 |
| SURVEY | Plain | 0.012 | 0.000 | 0.000 | |
| PARASYMPATHOMIMETICS | |||||
| CARBACHOL | |||||
| S01EB02 | SURVEY | Plain | 0.000 | 0.000 | 0.000 |
| PILOCARPINE | |||||
| S01EB01 | PBS/RPBS | Plain | 0.327 | 0.278 | 0.238 |
| SURVEY | Plain | 0.034 | 0.034 | 0.031 | |
| CARBONIC ANHYDRASE INHIBITORS | |||||
| ACETAZOLAMIDE | |||||
| S01EC01 | PBS/RPBS | Plain | 0.086 | 0.081 | 0.082 |
| SURVEY | Plain | 0.037 | 0.040 | 0.038 | |
| BRINZOLAMIDE | |||||
| S01EC04 | PBS/RPBS | Plain | 0.540 | 0.597 | 0.656 |
| SURVEY | Plain | 0.075 | 0.077 | 0.084 | |
| DORZOLAMIDE | |||||
| S01EC03 | PBS/RPBS | Plain | 0.108 | 0.108 | 0.106 |
| SURVEY | Plain | 0.018 | 0.017 | 0.015 | |
| BETA BLOCKING AGENTS | |||||
| BETAXOLOL HYDROCHLORIDE | |||||
| S01ED02 | PBS/RPBS | Plain | 0.361 | 0.307 | 0.261 |
| SURVEY | Plain | 0.043 | 0.036 | 0.034 | |
| LEVOBUNOLOL | |||||
| S01ED03 | PBS/RPBS | Plain | 0.028 | 0.000 | 0.000 |
| SURVEY | Plain | 0.004 | 0.000 | 0.000 | |
| TIMOLOL MALEATE | |||||
| S01ED01 | PBS/RPBS | Plain | 1.245 | 1.097 | 0.964 |
| SURVEY | Plain | 0.202 | 0.170 | 0.148 | |
| PROSTAGLANDIN ANALOGUES | |||||
| BIMATOPROST | |||||
| S01EE03 | PBS/RPBS | Plain | 1.105 | 1.099 | 1.032 |
| SURVEY | Plain | 0.003 | 0.004 | 0.003 | |
| LATANOPROST | |||||
| S01EE01 | PBS/RPBS | Plain | 4.714 | 4.665 | 4.675 |
S01 - OPHTHALMOLOGICALS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| SENSORY ORGANS OPHTHALMOLOGICALS ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
|||||
| SURVEY | Plain | 0.017 | 0.015 | 0.015 | |
| TRAVOPROST | |||||
| S01EE04 | PBS/RPBS | Plain | 0.424 | 0.414 | 0.443 |
| SURVEY | Plain | 0.002 | 0.002 | 0.003 | |
V03 - ALL OTHER THERAPEUTIC PRODUCTS
| ATC | PLAIN/ SOURCE |
COMBINATION | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|
| VARIOUS ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS DRUGS FOR TREATMENT OF HYPERKALEMIA AND HYPERPHOSPHATEMIA |
|||||
| LANTHANUM CARBONATE | |||||
| V03AE03 | PBS/RPBS | Plain | 0.000 | 0.003 | 0.013 |
| SEVELAMER | |||||
| V03AE02 | PBS/RPBS | Plain | 0.045 | 0.054 | 0.056 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
| DETOXIFYING AGENTS FOR CYTOSTATIC TREATMENT | |||||
| CALCIUM FOLINATE | |||||
| V03AF03 | PBS/RPBS | Plain | 0.034 | 0.032 | 0.030 |
| SURVEY | Plain | 0.000 | 0.000 | 0.000 | |
